209 results on '"Torres, AJ"'
Search Results
2. Impact of Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
- Author
-
Tabiri, Stephen, Kamarajah, Sivesh K, Nepogodiev, Dmitri, Li, Elizabeth, Simoes, Joana, Sravanam, Sanskrithi, Owusu, Sheila Agyeiwaa, Mahama, Haruna, Agyeman, Yaa Nyarko, Arthur, Joshua, Kunfah, Sheba Mary, Gyamfi, Frank Enoch, Owusu, Emmanuel Abem, Loffler, Markus W, Wandoh, Paul, Bhangu, Aneel, Siaw-Acheampong, Kwabena, Argus, Leah, Chaudhry, Daoud, Dawson, Brett E, Glasbey, James C, Gujjuri, Rohan R, Jones, Conor S, Khatri, Chetan, Keatley, James M, Lawday, Samuel, Mann, Harvinder, Marson, Ella J, Mclean, Kenneth A, Picciochi, Maria, Taylor, Elliott H, Tiwari, Abhinav, Simoes, Joana FF, Trout, Isobel M, Venn, Mary L, Wilkin, Richard JW, Dajti, Irida, Gjata, Arben, Boccalatte, Luis, Modolo, Maria Marta, Cox, Daniel, Pockney, Peter, Townend, Philip, Aigner, Felix, Kronberger, Irmgard, Hossain, Kamral, VanRamshorst, Gabrielle, Lawani, Ismail, Ataide, Gustavo, Baiocchi, Glauco, Buarque, Igor, Gohar, Muhammad, Slavchev, Mihail, Agarwal, Arnav, Brar, Amanpreet, Martin, Janet, Olivos, Maricarmen, Calvache, Jose, Perez Rivera, Carlos Jose, Hadzibegovic, Ana Danic, Kopjar, Tomislav, Mihanovic, Jakov, Klat, Jaroslav, Novysedlak, Rene, Christensen, Peter, El-Hussuna, Alaa, Batista, Sylvia, Lincango, Eddy, Emile, Sameh H, Mengesha, Mengistu Gebreyohanes, Hailu, Dr Samuel, Tamiru, Hailu, Kauppila, Joonas, Arnaud, Alexis, Albertsmeiers, Markus, Lederhuber, Hans, Loffler, Markus, Metallidis, Symeon, Tsoulfas, Georgios, Lorena, Maria Aguilera, Grecinos, Gustavo, Mersich, Tamas, Wettstein, Daniel, Ghosh, Dhruv, Kembuan, Gabriele, Brouk, Peiman, Khosravi, Mohammad, Mozafari, Masoud, Adil, Ahmed, Mohan, Helen M, Zmora, Oded, Fiore, Marco, Gallo, Gaetano, Pata, Francesco, Pellino, Gianluca, Satoi, Sohei, Ayasra, Faris, Chaar, Mohammad, Fakhradiyev, Ildar R, Jamal, Mohammad, Elhadi, Muhammed, Gulla, Aiste, Roslani, April, Martinez, Laura, Ramos De la Medina, Antonio, Outani, Oumaima, Jonker, Pascal, Kruijff, Schelto, Noltes, Milou, Steinkamp, Pieter, van der Plas, Willemijn, Ademuyiwa, Adesoji, Osinaike, Babatunde, Seyi-olajide, Justina, Williams, Emmanuel, Pejkova, Sofija, Augestad, Knut Magne, Soreide, Kjetil, Al Balushi, Zainab, Qureshi, Ahmad, Sayyed, Raza, Daraghmeh, Mustafa Abu Mohsen, Abukhalaf, Sadi, Cukier, Moises, Gomez, Hugo, Shu, Sebastian, Vasquez, Ximena, Parreno-Sacdalan, Marie Dione, Major, Piotr, Azevedo, Jose, Cunha, Miguel, Santos, Irene, Zarour, Ahmad, Bonci, Eduard-Alexandru, Negoi, Ionut, Efetov, Sergey, Litvin, Andrey, Ntirenganya, Faustin, AlAmeer, Ehab, Radenkovic, Dejan, Xiang, Frederick Koh Hong, Hoe, Chew Min, Yong, James Ngu Chi, Moore, Rachel, Nhlabathi, Ncamsile, Colino, Ruth Blanco, Bravo, Ana Minaya, Minaya-Bravo, Ana, Jayarajah, Umesh, Wickramasinghe, Dakshitha, Elmujtaba, Mohammed, Jebril, William, Rutegard, Martin, Sund, Malin, Isik, Arda, Leventoglu, Sezai, Abbott, Tom EF, Benson, Ruth, Caruna, Ed, Chakrabortee, Sohini, Demetriades, Andreas, Desai, Anant, Drake, Thomas D, Edwards, John G, Evans, Jonathan P, Ford, Samuel, Fotopoulou, Christina, Griffiths, Ewen, Hutchinson, Peter, Jenkinson, Michael D, Khan, Tabassum, Knight, Stephen, Kolias, Angelos, Leung, Elaine, McKay, Siobhan, Norman, Lisa, Ots, Riinu, Raghavan, Vidya, Roberts, Keith, Schache, Andrew, Shaw, Richard, Shaw, Katie, Smart, Neil, Stewart, Grant, Sundar, Sudha, Vimalchandran, Dale, Wright, Naomi, Alshryda, Sattar, Alser, Osaid, Breen, Kerry, Ganly, Ian, Kaafarani, Haytham, Kendall, Brittany, Mashbari, Hassan, Al Naggar, Hamza, Mazingi, Dennis, Dajti, I, Valenzuela, JI, Boccalatte, LA, Gemelli, NA, Smith, DE, Dudi-Venkata, NN, Kroon, HM, Sammour, T, Roberts, M, Mitchell, D, Lah, K, Pearce, A, Morton, A, Dawson, AC, Drane, A, Sharpin, C, Nataraja, RM, Pacilli, M, Cox, DRA, Muralidharan, V, Riddiough, GE, Clarke, EM, Jamel, W, Qin, KR, Pockney, P, Cope, D, Egoroff, N, Lott, N, Putnis, S, De Robles, S, Ang, Z, Mitteregger, M, Uranitsch, S, Stiegler, M, Seitinger, G, Aigner, F, Lumenta, DB, Nischwitz, SP, Richtig, E, Pau, M, Srekl-Filzmaier, P, Eibinger, N, Michelitsch, B, Fediuk, M, Papinutti, A, Seidel, G, Kahn, J, Cohnert, TU, Messner, F, Ofner, D, Presl, J, Varga, M, Weitzendorfer, M, Emmanuel, K, Binder, AD, Zimmermann, M, Holawe, S, Nkenke, E, Grimm, C, Kranawetter, M, Mitul, Rahman A, Islam, N, Karim, S, Komen, N, Ang, E, De Praetere, H, Tollens, T, Schols, G, Smets, C, Haenen, L, Quintens, J, Van Belle, K, Van Ramshorst, GH, Pattyn, P, Desender, L, Martens, T, Van de Putte, D, Lerut, P, Grimonprez, A, Janssen, M, De Smul, G, Wallaert, P, Van den Eynde, J, Oosterlinck, W, Van den Eynde, R, Sermon, A, Boeckxstaens, A, Cordonnier, A, De Coster, J, Jaekers, J, Politis, C, Miserez, M, Duchateau, N, De Gheldere, C, Flamey, N, Christiano, A, Guidi, B, Minussi, AL, Castro, S, Okoba, W, Maldonado, FHR, Oliveira, P, Baldasso, T, Santos, L, Gomes, GMA, Buarque, IL, Pol-Fachin, L, Bezerra, TS, Barros, AV, Leite, ALS, Silvestre, DWA, Ferro, CC, Araujo, MS, Lopes, LM, Damasceno, PD, Araujo, DHS, Laporte, G, Salem, MC, Guimaraes-Filho, MAC, Nacif, L, Flumignan, RLG, Nakano, LCU, Kuramoto, DAB, Aidar, ALS, Pereda, MR, Correia, RM, Santos, BC, Carvalho, AA, Amorim, JE, Guedes Neto, HJ, Areias, LL, Sousa, AF, Flumignan, CDQ, Lustre, WG, Moreno, DH, Barros-Jr, N, Baptista-Silva, JCC, Matos, LL, Kowaski, LP, Kulcsar, MAV, Nunes, KS, Teixeira, MF, Nunes, RL, Ijichi, TR, Kim, NJ, Marreiro, A, Muller, B, Awada, Barakat J, Baiocchi, G, Kowalski, LP, Vartanian, JG, Makdissi, FB, Aguiar, Jr S Jr, Marques, N, Carvalho, GB, Marques, TMDM, Abdallah, EA, Zurstrassen, CE, Gross, JL, Zequi, SC, Goncalves, BT, Santos, SS, Duprat, JP, Coimbra, FJF, Cicco, R, Takeda, F, Cecconello, I, Jr, Ribeiro Junior U, Gatti, A, Oliva, R, Nardi, C, Slavchev, M, Atanasov, B, Belev, N, Dell, A, Bigam, D, Dajani, K, Al Riyami, S, Martin, J, Cheng, D, Yang, H, Fayad, A, Carrier, FM, Amzallag, E, Desroches, J, Ruel, M, Caminsky, NG, Boutros, M, Moon, J, Wong, EG, Vanounou, T, Pelletier, J, Wong, S, Girsowicz, E, Bayne, J, Obrand, D, Gill, H, Steinmetz, O, MacKenzie, K, Lukaszewski, M, Jamjoum, G, Richebe, P, Verdonck, O, Discepola, S, Godin, N, Idrissi, M, Briatico, D, Sharma, S, Talwar, G, Bailey, K, Lecluyse, V, Cote, G, Demyttenaere, S, Garfinkle, R, Kouyoumdjian, A, Dumitra, S, Khwaja, K, Luo, L, Berry, G, Liberman, AS, Schmid, S, Spicer, J, Al Farsi, M, Abou-Khalil, J, Couture, E, Mohammadi, S, Tremblay, H, Gagne, N, Bergeron, A, Turgeon, AF, Costerousse, O, Bellemare, D, Babin, C, Blier, C, Wood, ML, Persad, A, Groot, G, D'Aragon, F, Carbonneau, E, Bouchard, M, Masse, M, Pesant, F, Heroux, J, Karanicolas, P, Hallet, J, Nadler, A, Nathens, A, Ko, M, Brar, A, Mayson, K, Kidane, B, Srinathan, S, Escudero, MI, Reyes, JT, Modolo, MM, Ramirez Nieto, P, Sepulveda, R, Bolbaran, A, Molero, A, Ruiz, I, Reyes, GP, Salas, R, Suazo, C, Munoz, R, Grasset, E, Inzunza, M, Besser, N, Irarrazaval, MJ, Jarry, C, Bellolio, F, Manqui, Romero CA, Esquide, Ruiz M, Fuentes, T, Campos, J, Perez Rivera, CJ, Cabrera, PA, Pinilla, RE, Guevara, O, Jimenez Ramirez, LJ, Velasquez Cuasquen, BG, Mora, Herrera DR, Bonilla, A, Diaz, S, Manrique, E, Facundo, H, Bernal, Velez JL, Garcia, M, Guzman, L, Lehmann, C, Cervera, S, Sanchez, Trujillo LM, Guevara, R, Valbuena, D, Suarez, L, Jimenez, G, Velandia, A, Vargas, J, Espinosa, J, Rey, S, Jairo, Mendoza Quevedo, Calvache, JA, Orozco-Chamorro, CM, Sanchez-Gomez, TA, Rojas-Tejada, DA, Mihanovic, J, Bakmaz, B, Rakvin, I, Sulen, N, Andabaka, T, Luksic, I, Mamic, M, Martinek, L, Skrovina, M, Peteja, M, Kristensen, H, Mekhael, M, Christensen, P, Westh, L, Smith, H, Haugstvedt, AF, Jonsson, ML, Crespo, A, Batista, S, Rodriguez-Abreu, J, Tactuk, N, Diaz-Delgado, PJ, Rivas, R, Sarmiento-Bobadilla, JA, Ashoush, F, Abdelaal, Samir A, Qatora, MS, Hewalla, Elsayed ME, Metwalli, M, Atta, R, Abdelmajeed, A, Abosamak, NE, Sabry, A, Shehata, S, Sallam, I, Amira, G, Sherief, M, Sherif, A, Salem, H, Hamdy, R, Aboulkassem, H, Ghaly, G, Sherif, G, Morsi, A, Abdelrahman, A, Ahmed, Omnia, Tawheed, A, El Kassas, M, Omar, W, Abdelsamed, A, Seleim, A, Azzam, AY, ElFiky, M, Nabil, A, Ibraheem, M, EL Deeb, M, Fawzy, M, Hamed, H, Emile, S, Elfallal, A, Elfeki, H, Shalaby, M, Sakr, A, Alrahawy, M, Atif, H, Soltan, H, Sayed, AK, Salah, A, Atiya, A, Wassim, K, Abbas, AM, Abd Elazeem, HAS, Abd-Elkariem, AY, Abd-Elkarem, MM, Alaa, S, Ali, AK, Ashraf, M, Ayman, A, Azizeldine, MG, Elkhayat, H, Mashhour, Emad A, Gaber, M, Hamza, HM, Hawal, I, Hetta, HF, Elghazaly, SM, Mohammed, MM, Monib, FA, Nageh, MA, Saad, A, Saad, MM, Shahine, M, Yousof, EA, Youssef, A, Esmail, E, Khalaf, M, Eldaly, A, Ghoneim, A, Hawila, A, Badr, H, Elhalaby, I, Abdel-bari, M, Elbahnasawy, M, Hamada, MK, Morsy, MS, Hammad, M, Essa, M, Fayed, MT, Elzoghby, M, Rady, M, Hamad, O, Salman, S, Sarsik, S, Abd-elsalam, S, Badr, Gamal S, El-Masry, Y, Moahmmed, MMH, Hailu, S, Wolde, A, Mengesha, M, Nida, S, Workneh, M, Ahmed, M, Fisseha, T, Kassa, D, Zeleke, H, Admasu, A, Laeke, T, Tirsit, A, Gessesse, M, Addissie, A, Bekele, K, Kauppila, JH, Sarjanoja, E, Testelin, S, Dakpe, S, Devauchelle, B, Bettoni, J, Lavagen, N, Schmitt, F, Lemee, JM, Boucher, S, Breheret, R, Kun-Darbois, JD, Kahn, A, Gueutier, A, Bigot, P, Borraccino, B, Lakkis, Z, Doussot, A, Heyd, B, Manfredelli, S, Mathieu, P, Paquette, B, Turco, C, Barrabe, A, Louvrier, A, Moszkowicz, D, Giovinazzo, D, Bretagnol, F, Police, A, Charre, L, Volpin, E, Braham, H, El Arbi, N, Villefranque, V, Bendjemar, L, Girard, E, Abba, J, Trilling, B, Chebaro, A, Lecolle, K, Truant, S, El Amrani, M, Zerbib, P, Pruvot, FR, Mathieu, D, Surmei, E, Mattei, L, Marin, H, Christou, N, Ballouhey, Q, Ferrero, P, Mazeau, Coste P, Tricard, J, Barrat, B, Taibi, A, Usseglio, J, Laloze, J, Salle, H, Fourcade, L, Duchalais, E, Regenet, N, Rigaud, J, Waast, D, Denis, W, Malard, O, Buffenoir, K, Espitalier, F, Ferron, C, Varenne, Y, Crenn, V, De Vergie, S, Cristini, J, Samarut, E, Tzedakis, S, Bouche, PA, Gaujoux, S, Kantor, E, Gossot, D, Seguin-Givelet, A, Fuks, D, Grigoroiu, M, Salas, Sanchez R, Cathelineau, X, Macek, P, Barbe, Y, Rozet, F, Barret, E, Mombet, A, Cathala, N, Brian, E, Zadegan, F, Conso, C, Blanc, T, Broch, A, Sarnacki, S, Ali, L, Bonnard, A, Peycelon, M, Hervieux, E, Clermidi, P, Maisonneuve, E, Aubry, E, Thomin, A, Langlais, T, Passot, G, Glehen, O, Cotte, E, Lifante, JC, De Simone, B, Chouillard, E, Arnaud, AP, Violas, P, Bergeat, D, Merdrignac, A, Scalabre, A, Perotto, LO, Le Roy, B, Haddad, E, Vermersch, S, Ezanno, AC, Barbier, O, Vigouroux, F, Malgras, B, Aime, A, Seeliger, B, Mutter, D, Philouze, G, Pessaux, P, Germain, A, Chanty, H, Ayav, A, Kassir, R, Von Theobald, P, Sauvat, F, O'Connor, J, Idiata, Mayombo M, O'Connor, Z, Tchoba, S, Modabber, A, Winnand, P, Holzle, F, Sommer, B, Shiban, E, Wolf, S, Anthuber, M, Sommer, F, Kaemmerer, D, Schreiber, T, Kamphues, C, Lauscher, JC, Schineis, C, Loch, FN, Beyer, K, Nasser, S, Sehouli, J, Hohn, P, Braumann, C, Reinkemeier, F, Uhl, W, Weitz, J, Bork, U, Welsch, T, Praetorius, C, Korn, S, Distler, M, Fluegen, G, Knoefel, WT, Vay, C, Golcher, H, Grutzmann, R, Binder, J, Meister, P, Gallinat, A, Paul, A, Schnitzbauer, AA, Thoenissen, P, El Youzouri, H, Schreckenbach, T, Nguyen, TA, Eberbach, H, Bayer, J, Erdle, B, Sandkamp, R, Nitschke, C, Izbicki, J, Uzunoglu, FG, Koenig, D, Gosau, M, Bottcher, A, Heuer, A, Klatte, TO, Priemel, M, Betz, CS, Burg, S, Mockelmann, N, Busch, CJ, Bewarder, J, Zeller, N, Smeets, R, Thole, S, Vollkommer, T, Speth, U, Stangenberg, M, Hakami, I, Boeker, C, Mall, J, Schardey, HM, Brunner, U, Tapking, C, Kneser, U, Hirche, C, Jung, M, Kowalewski, KF, Kienle, P, Reissfelder, C, Seyfried, S, Herrle, F, Hardt, J, Galata, C, Birgin, E, Rahbari, N, Vassos, N, Stoleriu, MG, Hatz, R, Albertsmeier, M, Borner, N, Lampert, C, Werner, J, Kuehlmann, B, Prantl, L, Brunner, SM, Schlitt, HJ, Brennfleck, F, Pfister, K, Oikonomou, K, Reinhard, T, Nowak, K, Ronellenfitsch, U, Kleeff, J, Delank, KS, Michalski, CW, Szabo, G, Widyaningsih, R, Stavrou, GA, Bschorer, R, Mielke, J, Peschel, T, Konigsrainer, A, Quante, M, Loffler, MW, Yurttas, C, Doerner, J, Seiberth, R, Bouchagier, K, Klimopoulos, S, Paspaliari, D, Stylianidis, G, Syllaios, A, Baili, E, Schizas, D, Liakakos, T, Charalabopoulos, A, Zografos, C, Spartalis, E, Manatakis, DK, Tasis, N, Antonopoulou, MI, Xenaki, S, Xynos, E, Chrysos, E, Athanasakis, E, Tsiaousis, J, Lostoridis, E, Tourountzi, P, Tzovaras, G, Tepetes, K, Zacharoulis, D, Baloyiannis, I, Perivoliotis, K, Hajiioannou, J, Korais, C, Gkrinia, E, Skoulakis, CE, Saratziotis, A, Koukoura, O, Symeonidis, D, Diamantis, A, Tsoulfas, G, Christou, CD, Tooulias, A, Papadopoulos, V, Anthoulakis, C, Grimbizis, G, Zouzoulas, D, Tsolakidis, D, Tatsis, D, Christidis, P, Loutzidou, L, Ioannidis, O, Astreidis, I, Antoniou, A, Antoniadis, K, Vachtsevanos, K, Paraskevopoulos, K, Kalaitsidou, I, Alexoudi, V, Stavroglou, A, Mantevas, A, Michailidou, D, Grivas, T, Deligiannidis, D, Politis, S, Duarte, Barrios A, Portilla, AL, Lowey, MJ, Recinos, G, Muralles, Lopez I, Siguantay, MA, Estrada, EE, Aguilera-Arevalo, ML, Cojulun, JM, Echeverria-Davila, G, Marin, C, de Marin, Icaza GC, Kok, SY, Joeng, HKM, Chan, LL, Lim, D, Novak, Z, Echim, T, Susztak, N, Banky, B, Kembuan, G, Pajan, H, Islam, AA, Rahim, F, Safari, H, Mozafari, M, Milan, Brouki P, Tizmaghz, A, Tavirani, Rezaei M, Ahmed, A, Hussein, R, Fleming, C, OBrien, S, Kayyal, MY, Daly, A, Killeen, S, Corrigan, M, De Marchi, J, Hill, A, Farrell, T, Davis, NF, Kearney, D, Nelson, T, Maguire, PJ, Barry, C, Farrell, R, Smith, LA, Mohan, HM, Mehigan, BJ, Mccormick, P, Larkin, JO, Fahey, BA, Rogers, A, Donlon, N, OSullivan, H, Nugent, T, Reynolds, JV, Donohue, C, Shokuhi, P, Ravi, N, Fitzgerald, C, Lennon, P, Timon, C, Kinsella, J, Smith, J, Boyle, T, Alazawi, D, Connolly, E, Butt, W, Croghan, SM, Manecksha, RP, Fearon, N, Winter, D, Heneghan, H, Maguire, D, Gallagher, T, Conlon, K, Kennedy, N, Martin, S, Kennelly, R, Hanly, A, Ng, KC, Fagan, J, Geary, E, Cullinane, C, Carrington, E, Geraghty, J, McDermott, E, Pritchard, R, McPartland, D, Boland, M, Stafford, A, Geoghegan, J, Elliott, JA, Ridgway, PF, Gillis, AE, Bass, GA, Neary, PC, Jm, ORiordan, Kavanagh, DO, Reynolds, IS, Joyce, DP, Boyle, E, Egan, B, Whelan, M, Elkady, R, Tierney, S, Connelly, TM, Earley, H, Umair, M, OConnell, C, Thomas, AZ, Rice, D, Madden, A, Bashir, Y, Creavin, B, Cullivan, O, Owens, P, Canas-Martinez, A, Murphy, C, Pickett, L, Murphy, B, Mastrosimone, A, Beddy, D, Arumugasamy, M, Allen, M, Aremu, M, McCarthy, C, OConnor, C, O'Connor, DB, Kent, E, Malone, F, Geary, M, McKevitt, KL, Lowery, AJ, Ryan, EJ, Aherne, TM, Fowler, A, Hassanin, A, Hogan, AM, Collins, CG, Finnegan, L, Carroll, PA, Kerin, MJ, Walsh, SR, Nally, D, Peirce, C, Coffey, JC, Cunningham, RM, Tormey, S, Hardy, NP, Neary, PM, Muallem-Kalmovich, L, Kugler, N, Lavy, R, Zmora, O, Horesh, N, Vergari, R, Mochet, S, Barmasse, R, Usai, A, Morelli, L, Picciariello, A, Papagni, V, Altomare, DF, Colledan, M, Zambelli, MF, Tornese, S, Camillo, A, Rausa, E, Bianco, F, Lucianetti, A, Prucher, GM, Baietti, AM, Ruggiero, F, Maremonti, P, Neri, F, Ricci, S, Biasini, M, Zarabini, AG, Belvedere, A, Bernante, P, Bertoglio, P, Boussedra, S, Brunocilla, E, Cipriani, R, Cisternino, G, De Crescenzo, E, De Iaco, P, Della Gatta, AN, Dondi, G, Frio, F, Jovine, E, Bianchi, Mineo F, Neri, J, Parlanti, D, Perrone, AM, Pezzuto, AP, Pignatti, M, Pilu, G, Pinto, V, Poggioli, G, Ravaioli, M, Rottoli, M, Schiavina, R, Serenari, M, Serra, M, Solli, P, Taffurelli, M, Tanzanu, M, Tesei, M, Violante, T, Zanotti, S, Tonini, V, Sartarelli, L, Cervellera, M, Gori, A, Armatura, G, Scotton, G, Patauner, S, Frena, A, Podda, M, Pisanu, A, Esposito, G, Frongia, F, Abate, E, Laface, L, Casati, M, Schiavo, M, Casiraghi, T, Sammarco, G, Gallo, G, Vescio, G, Fulginiti, S, Scorcia, V, Giannaccare, G, Carnevali, A, Giuffrida, MC, Marano, A, Palagi, S, Grimaldi, Di Maria S, Testa, V, Peluso, C, Borghi, F, Simonato, A, Puppo, A, Chiarpenello, R, Pellegrino, L, Maione, F, Cianflocca, D, Ciarello, Pruiti V, Giraudo, G, Gelarda, E, Dalmasso, E, Abrate, A, Daniele, A, Ciriello, V, Rosato, F, Garnero, A, Leotta, L, Giacometti, M, Zonta, S, Lomiento, D, Taglietti, L, Dester, S, Compagnoni, B, Viotti, F, Cazzaniga, R, Del Giudice, R, Mazzotti, F, Pasini, F, Ugolini, G, Fabbri, N, Feo, CV, Righini, E, Gennari, S, Chiozza, M, Anania, G, Urbani, A, Radica, Koleva M, Carcoforo, P, Portinari, M, Sibilla, M, Anastasi, A, Bartalucci, B, Bellacci, A, Canonico, G, Capezzuoli, L, Di Martino, C, Ipponi, P, Linari, C, Montelatici, M, Nelli, T, Spagni, G, Tirloni, L, Vitali, A, Agostini, C, Alemanno, G, Bartolini, I, Bergamini, C, Bruscino, A, Checcucci, C, De Vincenti, R, Di Bella, A, Fambrini, M, Fortuna, L, Maltinti, G, Muiesan, P, Petraglia, F, Prosperi, P, Ringressi, MN, Risaliti, M, Sorbi, F, Taddei, A, Lizzi, V, Vovola, F, Arminio, A, Cotoia, A, Sarni, AL, Familiari, P, Picotti, V, Bambina, F, Fontana, T, Barra, F, Ferrero, S, Gustavino, C, Kratochwila, C, Ferraiolo, A, Costantini, S, Batistotti, P, Aprile, A, Almondo, C, Ball, L, Robba, C, Scabini, S, Pertile, D, Massobrio, A, Soriero, D, D'Ugo, S, Depalma, N, Spampinato, MG, Lippa, L, Gambacciani, C, Santonocito, OS, Aquila, F, Pieri, F, Ballabio, M, Bisagni, P, Longhi, M, Armao, T, Madonini, M, Gagliano, A, Pizzini, P, Costanzi, A, Confalonieri, M, Monteleone, M, Colletti, G, Frattaruolo, C, Mari, G, Spinelli, A, Mercante, G, Spriano, G, Gaino, F, Ferreli, F, De Virgilio, A, Rossi, V, Carvello, MM, Di Candido, F, Kurihara, H, Marrano, E, Torzilli, G, Castoro, C, Carrano, FM, Martinelli, F, Macchi, A, Fiore, M, Pasquali, S, Cioffi, SPB, Baia, M, Abatini, C, Sarre, C, Mosca, A, Biasoni, D, Gronchi, A, Citterio, D, Mazzaferro, V, Cadenelli, P, Gennaro, M, Capizzi, V, Guaglio, M, Sorrentino, L, Bogani, G, Sarpietro, G, Giannini, L, Comini, LV, Rolli, L, Folli, S, Raspagliesi, F, Piazza, C, Cosimelli, M, Salvioni, R, Antonelli, B, Baldari, L, Boni, L, Cassinotti, E, Pignataro, L, Rossi, G, Torretta, S, Beltramini, GA, Gianni, A, Tagliabue, M, De Berardinis, R, Pietrobon, G, Chu, F, Cenciarelli, S, Adamoli, L, Ansarin, M, Romario, Fumagalli U, Mastrilli, F, Mariani, NM, Nicastro, V, Cellerino, P, Colombo, F, Frontali, A, Bondurri, A, Guerci, C, Maffioli, A, Ferrario, L, Candiani, M, Bonavina, G, Ottolina, J, Valsecchi, L, Mortini, P, Gagliardi, F, Piloni, M, Medone, M, Negri, G, Bandiera, A, De Nardi, P, Sileri, P, Carlucci, M, Pelaggi, D, Rosati, R, Vignali, A, Parise, P, Elmore, U, Tamini, N, Nespoli, LC, Rennis, M, Pitoni, L, Chiappetta, MF, Vico, E, Fruscio, R, Grassi, T, Sasia, D, Migliore, M, Gattolin, A, Rimonda, R, Travaglio, E, Olearo, E, Tufo, A, Marra, E, Maida, P, Marte, G, Tammaro, P, Incollingo, P, Izzo, F, Belli, A, Patrone, R, Albino, V, Leongito, M, Granata, V, Piccirillo, M, Palaia, R, Francone, E, Gentilli, S, Nikaj, H, Fiorini, A, Norcini, C, Chessa, A, Marino, MV, Mirabella, A, Vaccarella, G, Musini, L, Ampollini, L, Bergonzani, M, Varazzani, A, Bellanti, L, Domenichini, M, Cabrini, E, Fornasari, A, Freyrie, A, Dejana, DO, DAngelo, G, Bertoli, G, Di Lella, F, Bocchialini, G, Falcioni, M, Lanfranco, D, Poli, T, Giuffrida, M, Annicchiarico, A, Perrone, G, Catena, F, Raffaele, A, Garberini, De Manzoni A, Baldini, E, Conti, L, Ribolla, M, Capelli, P, Isolani, SM, Maniscalco, P, Cauteruccio, M, Ciatti, C, Pagliarello, Puma C, Gattoni, S, Galleano, R, Malerba, M, Ciciliot, M, Farnesi, F, Calabro, M, Federico, Pipitone NS, Lunghi, EG, Muratore, A, Di Franco, G, Palmeri, M, Tartaglia, D, Coccolini, F, Chiarugi, M, Simoncini, T, Gadducci, A, Caretto, M, Giannini, A, Perutelli, A, Domenici, L, Garibaldi, S, Capanna, R, Andreani, L, Furbetta, N, Guadagni, S, Bianchini, M, Gianardi, D, Pinotti, E, Montuori, M, Carissimi, F, Baronio, G, Zizzo, M, Ruiz, Castro C, Annessi, V, Montella, MT, Falco, G, Mele, S, Ferrari, G, Mastrofilippo, V, Mandato, VD, Aguzzoli, L, Corbellini, C, Baldi, C, Sampietro, GM, Palini, GM, Zanini, N, Garulli, G, Barone, R, Murgese, A, Mungo, S, Grasso, M, Marafante, C, Birolo, SL, Moggia, E, Caccetta, M, Masciandaro, A, Deirino, A, Garino, M, Perinotti, R, Maiello, F, Gordini, L, Lombardi, CP, Marzi, F, Marra, AA, Ratto, C, Di Muro, M, Litta, F, De Simone, V, Cozza, V, Rosa, F, Agnes, A, Parello, A, Alfieri, S, Sganga, G, Lapolla, P, Mingoli, A, De Toma, G, Fiori, E, La Torre, F, Sapienza, P, Brachini, G, Cirillo, B, Iannone, I, Zambon, M, Chiappini, A, Meneghini, S, Fonsi, GB, Cicerchia, PM, Bruzzaniti, P, Santoro, A, Frati, A, Marruzzo, G, Ribuffo, D, Sagnotta, A, Cosentino, Marino L, Mancini, S, Lisi, G, Spoletini, D, Campanelli, Bellato VM, Sica, G, Siragusa, L, Bonavina, L, Asti, E, Bernardi, D, Lovece, A, Perra, T, Porcu, A, Fancellu, A, Feo, CF, Scanu, AM, Tuminello, F, Franceschi, A, Langone, A, Fleres, F, Spolini, A, Bordoni, P, Franzini, M, Clarizia, G, Grechi, A, Longhini, A, Guaitoli, E, Manca, G, Grossi, U, Novello, S, Zanus, G, Romano, M, Rossi, S, Ferrara, F, La Torre, M, Pirozzolo, G, Recordare, A, Paiella, S, Turri, G, Rattizzato, S, Campagnaro, T, Guglielmi, A, Pedrazzani, C, Ruzzenente, A, Poletto, E, Conci, S, Casetti, L, Fontana, M, Salvia, R, Malleo, G, Esposito, A, Landoni, L, De Pastena, M, Bassi, C, Tuveri, M, Nobile, S, Marchegiani, G, Bortolasi, L, Sambugaro, E, Malavolta, M, Moretto, G, Impellizzeri, H, Inama, M, Barugola, G, Ascari, F, Ruffo, G, Granieri, S, Cotsoglou, C, Berselli, M, Desio, M, Marchionini, V, Cocozza, E, Di Saverio, S, Ietto, G, Iovino, D, Carcano, G, Ayasra, F, Qasem, A, Ayasra, Y, Al-Masri, M, Abou Chaar, MK, Al-Najjar, H, Ghandour, K, Alawneh, F, Jalil, Abdel R, Abdel, ALS, Elayyan, M, Ghanem, R, Lataifeh, I, Alsaraireh, O, Abu Za'nouneh, FJ, Fahmawee, T, Ibrahim, A, Obeidat, K, Lee, KJ, Shin, SJ, Chung, H, Albader, I, Alabbad, J, Albader, MAS, Bouhuwaish, A, Taher, AS, Omar, MSM, Abdulwahed, E, Biala, M, Morgom, M, Elhadi, A, Alarabi, A, Msherghi, A, Elhajdawe, F, Alsoufi, A, Salamah, A, Salama, H, Bulugma, M, Almabrouk, H, Venskutonis, D, Dainius, E, Kubiliute, E, Bradulskis, S, Parseliunas, A, Kutkevicius, J, Subocius, A, Cheong, YJ, Masood, MS, Ngo, CW, Saravanan, R, Maei, Abdul N, Hayati, F, Sahid, Amin N, Reyes, Yanowsky G, Perez, Orozco J, Damian, R, Ortiz, Santana R, Tinajero, Colunga CA, Cordera, F, Gomez-Pedraza, A, Maffuz-Aziz, A, Posada, JA, Abaroa, De la Rosa MA, Alvarez, MR, Arrangoiz, R, Hernandez, R, Gutierrez, Bozada K, Trejo-Avila, M, Valenzuela-Salazar, C, Herrera-Esquivel, J, Moreno-Portillo, M, Vm, Pinto-Angulo, Ee, Sosa-Duran, Ziad-Aboharp, H, Villanueva, Jimenez X, Martinez, Soule CE, Lupian-Angulo, AI, Jacobo, Martinez Zarate J, Rodriguez, Reyes E, Dominguez, Montalvo G, Garcia, Becerra FC, Melchor-Ruan, J, Vilar-Compte, D, Romero-Banuelos, E, Herrera-Gomez, A, Meneses-Garcia, A, Isla-Ortiz, D, Salcedo-Hernandez, RA, Hernandez-Nava, JM, Morales-Castelan, JE, Posadas-Trujillo, OE, Buerba, GA, Alfaro-Goldaracena, A, Gomez-Portugal, Pena E, Lopez-Pena, G, Hinojosa, CA, Mercado, MA, Ramos-De La Medina, A, Martinez, L, Duran, I, Gonzalez, DS, Martinez, MJ, de la Fuente, Nayen Sainz A, Miguelena, L, Miguelena, Hernandez L, Louraoui, SM, El Azhari, A, Rghioui, M, Khya, E, Ghannam, A, Souadka, A, El Ahmadi, B, Belkhadir, ZH, Majbar, MA, Benkabbou, A, Mohsine, R, Oudrhiri, MY, Bechri, H, Arkha, Y, El Ouahabi, A, Frima, H, Bachiri, S, Groen, LC, Verhagen, T, Scheijmans, JCG, Boermeester, MA, Hompes, R, Praag, Meima-van EM, Sharabiany, S, Borgstein, ABJ, Gisbertz, SS, Gans, S, Van Duijvendijk, P, Herklots, T, De Hoop, T, De Graaff, MR, Sloothaak, D, Bolster-van Eenennaam, M, Baaij, J, Klinkenbijl, JHG, Van Eekeren, R, Bilgen, Spillenaar EJ, Van Der Burg, SW, Harlaar, NJ, Jonker, FHW, Vermaas, M, Voigt, KR, Nellensteijn, D, Bensi, EAB, Posma-Bouman, L, Van Sambeek, M, Holscher, M, Van den Broek, WT, HKruijff, S, De Vries, JPPM, Steinkamp, PJ, Jonker, PKC, Van der Plas, WY, Bierman, W, Janssen, Y, Franken, J, Oosterling, S, Boerma, EG, Schweitzer, D, Keulen, MHF, Ketting, S, Wegdam, JA, Reilingh, Vries TS de, Schipper, E, Teeuwen, PHE, Hendriks, ER, Van Geloven, AAW, Emous, M, Poelstra, R, Teunissen, M, Gerritsen, SL, Boerma, D, De Reuver, PR, Thunnissen, F, Vermeulen, BAM, Groen, A, Van Ginhoven, TM, Cl, Vietor, Pw, Vriens HE, Houwen, T, Heisterkamp, J, Stevens, CT, Pronk, A, Bakker, WJ, Richir, MC, Vriens, MR, Filipe, MD, Uittenbogaart, M, Leclercq, WKG, Sijmons, JML, Vancoillie, PJ, Konsten, J, Van Heinsbergen, M, Dekker, NAM, Akinmade, A, Adeyeye, A, Enoch, E, Fayose, S, Okunlola, AI, Adeniyi, AA, Adeyemo, OT, Adebara, IO, Bakare, A, Babalola, OF, Abiyere, OH, Banjo, OO, Olori, S, Akaba, OG, Agida, ET, Abdullahi, IH, Egbuchulem, IK, Olulana, D, Lawal, TA, Ogundoyin, O, Oyelakin, OA, Nwaorgu, OG, Sule, SO, Makwe, CC, Afolabi, BB, Seyi-Olajide, JO, Ademuyiwa, AO, Bode, CO, Atoyebi, O, Elebute, OA, Okunowo, AA, Williams, OM, Eke, NG, Oshodi, OA, Faboya, OM, Adeniran, AS, Omisanjo, OA, Oshodi, YA, Ogunyemi, AA, Atobatele, KM, Aremu, I, Olasehinde, O, Abdur-Rahman, L, Bello, J, Popoola, A, Sayomi, TO, Raji, HO, Adeleke, N, Lawal, B, Habeeb, O, Agodirin, O, Tolani, MA, Sholadoye, TT, Nwabuoku, SE, Abubakar, M, Risteski, T, Naunova, Cvetanovska V, Jovcheski, L, Lazova, E, Agledahl, I, Breuer, RG, Massoud, J, Waqar, SH, Rashid, I, Ayubi, A, Bhatti, ABH, Younis, MU, Ghouri, A, Ayub, B, Sayyed, RH, Saleem, A, Turk, K, Alvi, A, Abassy, J, Khan, S, Arshad, M, Ahmed, K, Siddiqui, T, Pirzada, A, Kerawala, AA, Jamal, A, Rai, L, Ahmed, Nafees R, Memon, AS, Qureshi, AU, Ayyaz, M, Umar, M, Butt, U, Kashif, M, Khan, WH, Farooka, Waris M, Wasim, T, Talat, N, Tahir, W, Naseem, J, Akbar, A, Afroze, S, Sultan, A, Ali, HB, Janjua, MH, Janjua, A, Asghar, S, Farooq, MS, Sarwar, MZ, Naqi, SA, Gondal, KM, Bukhari, SI, Tariq, M, Javed, S, Yaqoob, E, Mahmood, U, Shabbir, Raja K, Abukhalaf, SA, Amro, A, Lee, Cabada JM, Aguilar, A, Rodriguez, E, Castillo, K, Cukier, M, Rodriguez-Zentner, H, Arrue, E, Beron, Isaacs R, Rodriguez Gonzalez, A, Panduro-Correa, V, Cornelio, DK, Otiniano Alvarado, CE, Caballero Sarabia, VD, Vasquez-Ojeda, XP, Lizzetti-Mendoza, G, Niquen-Jimenez, M, Shu-Yip, SB, Leon Palacios, JL, Borda-Luque, G, Zegarra, SA, Egoavil, Huaman E, Carmelo, Suazo C, de la Mata, Castro R, Rivas, D, Targarona, J, Trujillo, Y, Villanueva, Olivera M, Lahoud-Velaochaga, A, Cabillas, K, Castaneda, W, Casas, Colina J, Pallardel, Betalleluz J, Zacarias, Camacho F, Segura, Velez E, Condori, Cruz DL, Huaman, E, Oscco, Ugarte R, Cabrera, Vergel C, Colmenares, Carpio YT, La, Garcia Barrionuevo, de Castilla, Cardenas Ruiz D, Doria, Mansilla P, Li Valencia, MR, Salazar, A, Sarmiento, A, Diaz, C, Morales, E, Ore, E, Zegarra, H, Siccha, J, Guardia, M, Sandoval, M, Mendiola, GC, Mimbela, M, Diaz-Ruiz, R, Zeta, LA, Cordova-Calle, E, Nunez, HM, Ortiz-Argomedo, MR, Caballero-Alvarado, J, Salazar-Tantalean, A, Espinoza-Llerena, R, Aliaga-Ramos, M, Asodisen, O, Jabagat, E, Tedoy, CM, Ramos, RA, Lopez, MPJ, Violago, KLE, Aram, R, Santos, Carlos P, RFCarlos, Filarca A, Santos, P, Filarca, RL, Domingo, EJ, Khu, KJO, Lapitan, MC, Sacdalan, MDP, Kho, MJN, Baticulon, RE, Bravo, SLR, Cueto, MAC, Ramos, CL, Fuentes, JR, Sadian, H, Gumarao, A, Barraquio, A, Cruz, EM, Gonzales, AD, Reyes, JAS, Salud, JA, Tancinco, EG, Rivera, RD, Lim, JA, Barcelon, JC, Chiu, JA, Carballo, MI, Major, P, Gawron, I, Jach, R, Borges, F, Costa, Matos P, Henriques, S, Rodrigues, SC, Goncalves, N, Curvas, JM, Cabeleira, A, Branco, C, Serralheiro, P, Alves, R, Teles, T, Lazaro, A, Canhoto, C, Simoes, J, Costa, M, Almeida, AC, Nogueira, O, Oliveira, A, Nemesio, Athayde R, Silva, M, Lopes, C, Amaral, MJ, da Costa, Valente A, Andrade, R, Martins, R, Guimaraes, A, Guerreiro, P, Ruivo, A, Camacho, C, Duque, M, Santos, E, Breda, D, Oliveira, JM, Lopez, De Oliveira AL, Garrido, S, Colino, M, De Barros, J, Correia, S, Rodrigues, M, Cardoso, P, Teixeira, J, Soares, AP, Morais, H, Pereira, R, Revez, T, Manso, MI, Domingues, JC, Henriques, P, Ribeiro, R, Ribeiro, VI, Cardoso, N, Sousa, S, dos Santos, Martins G, Carvalho, L, Osorio, C, Antunes, J, Lourenco, S, Balau, P, Godinho, M, Pereira, A, Silva, N, Andrade, Kam da Silva A, Rodrigues, Pereira A, Borges, N, Correia, J, Vieira, I, Ribeiro, T, Catarino, J, Correia, R, Pais, F, Garcia, Carreira R, Bento, R, Cardoso, J, Luis, M, Henriques, J, Forte, Patena J, Maciel, J, Santos, Pinheiro J, Silva, TP, Branquinho, A, Caiado, A, Miranda, P, Garrido, R, Ferreira, Peralta M, Ascensao, J, Costeira, B, Cunha, C, Rodrigues, Rio L, Fernandes, Sousa M, Azevedo, P, Ribeiro, J, Lourenco, I, Gomes, H, Mendinhos, G, Pinto, Nobre A, Ribeiro, A, Gil, CG, Lima-da-Silva, C, Pereira, C, Tavares, F, Ferraz, I, Almeida, JI, Marialva, J, Lopes, L, Mj, Costa MA, Nunes-Coelho, M, Teixeira, MJ, Machado, N, Alfonso, JP, Saraiva, P, Silva, RL, Santos, R, Almeida-Reis, R, Correia-de-Sa, T, Fernandes, V, Almeida-Pinto, J, Goncalves, JP, Santos-Sousa, H, Cavaleiro, S, Leite-Moreira, AM, Pereira-Neves, A, Faria, CS, Monteiro, JM, Nogueiro, J, Sampaio-Alves, M, Maia, Magalhaes M, Vieira, P, Pina-Vaz, T, Jacome, F, Devezas, V, Almeida, A, Silveira, H, Vaz, S, Rodrigues, Castanheira S, Santos, Costa D, Grilo, JV, da Silva, Abreu A, Claro, M, Deus, AC, Branquinho, R, Santos, PMDD, Patricio, B, Lopes, Vieira Paiva AC, Mendes, JM, Carvalho, MF, Oliveira, CM, Tojal, A, Pinto, J, Abutaka, A, Zarour, A, Abdelkareem, M, Ali, SM, Al Tarakji, M, Alfkey, R, Mukhtar, K, Wani, IR, Singh, R, Bouchiba, N, Mahdi, H, Mustafa, Abdelaziem S, Al Ansari, A, Drasovean, R, Caziuc, A, Galliamov, E, Agapov, M, Kakotkin, V, Semina, E, Kubyshkin, V, Kamalov, A, Efetov, SK, Kochetkov, VS, Garmanova, T, Tsarkov, P, Tulina, I, Rodimov, S, Markaryan, D, Kazachenko, E, Yanishev, A, Abelevich, A, Bazaev, A, Kokobelyan, A, Zarubenko, P, Zakharenko, A, Novikova, A, Kim, G, Shmatov, D, Stoliarov, M, Kamenskikh, M, Nambi, G, Almulhim, AS, Madkhali, T, Alzouhir, A, Alissa, A, Alameer, E, Badedi, M, Alnami, AQ, Darraj, H, Alkhuzaie, A, Khadwardi, F, Abualjadayel, M, Tashkandi, W, Farsi, A, Malibary, N, Trabulsi, N, Farsi, S, Bayazeed, Said A, Nasser, M, Siddiqui, MS, Al Awwad, S, Alshahrani, M, Alsharif, F, Fahmi, MW, Gudal, A, Alasmari, A, Alqahtani, S, Majrashi, S, Mashat, A, Al Raddadi, R, Alharbi, A, Nasser, Y, Hamayel, H, Alhojaili, A, Aljohani, R, Sogair, O, Alfarhan, O, Alzahrani, A, Alzomaili, B, Azab, AM, Alotaibi, M, Maashi, A, Zowgar, A, Alsakkaf, M, Alnemary, M, Khayat, S, Felmban, S, Almhmadi, A, Alqannas, M, Guiral, Cortes D, Alyami, M, Elawad, A, Alhefdhi, A, Alresaini, F, Kurdi, W, Tulbah, M, Aldakheel, M, Alsahan, N, Koussayer, S, Elsheikh, H, Al-qattan, M, Alshanafey, S, Rafique, A, Mahabbat, N, Saeed, B, Al-Kharashi, E, Alsowaina, K, Arab, N, Aljaber, F, Al Hasan, I, Alghamdi, A, Badahdah, F, Alghuliga, A, Abdulfattah, F, Alanazi, F, Albaqami, F, Alsuhaibani, A, AlFakhri, A, Alqasem, S, Alajaji, N, Nouh, T, Bin Nasser, A, Alowais, J, Alburakan, A, Alamri, O, Albdah, A, Alawi, K, Alshalhoub, M, ElSanhoury, K, Almofarreh, A, Ibrahim, S, Elshafie, H, Osman, I, Guzman, T, Mutair, H, Siddiqui, A, Chowdhury, S, Alghamdi, R, Almutrafi, S, Alfaifi, J, DSouza, J, Alshitwi, A, Alkreedees, N, Alramadhan, M, Alshehri, M, Alobaysi, S, Alshahrani, A, Alshehri, A, Alrashed, M, Altahan, T, Alsabahi, T, Alhossaini, R, Sbaih, M, Alalawi, Y, Alnwijy, K, Al Ayed, A, Ghedan, S, Alharthi, R, Awad, S, Sharara, IM, Abdelrhman, S, Althobaiti, W, Srbinovic, L, Perovic, M, Mikovic, Z, Nikolic, B, Vasiljevic, M, Pazin, V, Markovic, Mandic V, Dimitrijevic, D, Zecevic, N, Gregoric, P, Micic, D, Loncar, Z, Doklestic, K, Ivancevic, N, Djukic, V, Stojakov, D, Ilic, R, Savic, P, Pijanovic, N, Milanovic, M, Radosavljevic, M, Dejanovic, T, Kostic, M, Paskas, J, Bojic, S, Stevanovic, P, Djuric, M, Kadija, M, Tulic, G, Jovanovic, Glisovic I, Lieske, B, Kayombo, E, Kruger, I, De Kock, M, Malan, A, Ferreira, C, Du Preez, H, Mulder, W, Noel, C, Le Grange, S, Lusawana, O, Kies, C, Steyn, E, Janson, J, Buitendag, JJP, Chu, K, Mihalik, M, Nel, R, Naidoo, S, Kloppers, C, Nel, D, Jonas, E, Pickard, H, Bernon, M, Almgla, N, Rayamajhi, S, Mugla, W, Carapinha, C, Hyman, GY, Fourtounas, M, Moore, R, Mozo, Sanchez A, Lopez, Aguado H, Pinedo, Zarate A, Toscano, Jimenez M, de la Fuente, Alonso N, Mancebo, G, Cecchini, L, Munarriz, M, Labat, Cazador M, Campillo, Lopez A, Martorell, P, Espinosa, CA, Vivancos, Caja P, Ateca, Villalabeitia I, Calvo, Prieto M, Playa, Martin P, Gainza, A, Achig, Aragon EJ, Fraga, Rodriguez A, Corcostegui, Melchor I, Ormaechea, Mallabiabarrena G, Gutierrez, Garcia JJ, Barbier, L, Peralta, Pesantez MA, Jimenez, Jimenez M, Martin, Municio JA, Suarez, Gomez J, Opere, Garcia G, Gomez, Pascua LA, Aguirre, Onate M, Fernandez-Colorado, A, De la Rosa-Estadella, M, Gasulla-Rodriguez, A, Serrano-Martin, M, Peig-Font, A, Junca-Marti, S, Juarez-Pomes, M, Garrido-Ondono, S, Blasco-Torres, L, Molina-Corbacho, M, Maldonado-Sotoca, Y, Gasset-Teixidor, A, Blasco-Moreu, J, Fernandez, Gomez L, Paniagua, Cayetano L, Izquierdo, O, Ventura, D, Castellanos, J, Vazquez, Ballester E, Lopez, Sanchez A, Ponz, Balague C, Soler, Targarona EM, Cabus, Sanchez S, Santos, Molina V, Lopez, Gonzalez JA, Caviedes, Medrano R, Duarte, Moral A, Espin-Basany, E, Pellino, G, Blanco-Colino, R, Turrado-Rodriguez, V, Lacy, AM, Morales, X, Carreras-Castaner, A, Torner, P, Jornet-Gibert, M, Balaguer-Castro, M, Renau-Cerrillo, M, Camacho-Carrasco, P, Vives-Barquiel, M, Campuzano-Bitterling, B, Gracia, I, Pujol-Muncunill, R, Martin-Sole, O, Rubio-Palau, J, Tarrado, X, Garcia-Aparicio, L, Jorge, De Haro I, Martin, A, Rojas-Ticona, J, Perez-Bertolez, S, Argos, Cuesta M, Vilaro, Capdevila B, Soucheiron, Coronas M, Martinez, Riba M, Garcia, Saura L, Ortells, Prat J, Serrano, Bejarano M, Parri, P, Massaguer, C, Vicario, F, Bellver, Palazon P, Gudayol, Moraleda I, Lara, A, Escobar, D, Arrieta, M, de Cortazar, Garcia U, Garcia, Villamor I, Landaluce-olavarria, A, De Miguel, Gonzalez M, Cruzado, Fernandez Gomez L, Begona, E, Lecumberri, D, Merida, Acosta MA, Cano, Yepes AF, Gomez, Estaire M, Padilla-Valverde, D, Sanchez-Garcia, S, Sanchez-Pelaez, D, Higuera, Jimenez E, Rodriguez, Picon R, Camunas, Fernandez A, Martinez-Pinedo, C, Santos, Garcia EP, Munoz-Atienza, V, Perez, Moreno A, de la Manzanara Cano, Lopez CA, Ugarte-Sierra, B, Ibanez-Aguirre, FJ, Olabarria, De Andres U, Fernandez Pablos, FJ, Ballesteros, Duran M, Larrainzar, Sanz A, Carneros, Jimenez V, Rubio, Valle A, Alonso-Lamberti, L, Garcia-Quijada, J, Leon, R, Rodriguez, JL, Miramon, Jimenez J, Jover, JM, Salamanca, Martin MB, Assaf, M, Simon, Perez V, Aguero, Landeo SA, Pintado, Baeza N, Fernandez, Huertas MA, Carabias, A, Sosa, MV, Lora-Cumplido, P, Lanuza, L, Eri, Galipienso M, Montesino, Garcia JD, Frigole, Dellonder J, Munoz, Noriego D, Navarro-Sanchez, A, Enjuto, D, Gonzalez, Perez M, Pena, Diaz P, Gonzalez, J, De Salas, Marqueta M, Pascual, Martinez P, Gomez, Rodriguez L, Garcia, Garces R, Bonilla, Ramos A, Herrera-Merino, N, Bernabe, Fernandez P, Ortega, Cagigal EP, Hernandez, I, Rubio, Garcia de Castro E, Cervera, I, Sanchez-Guillen, L, Fernandez-Candela, A, Curtis-Martinez, C, Soler-Silva, A, Oller, A, Triguero-Canovas, D, Bosch-Ramirez, M, Lillo, C, Lario, S, Arroyo, A, Segura-Illa, Espino M, Aniceto, Sanchez G, Castano-Leon, AM, Jimenez-Roldan, L, Fernandez, Delgado J, Nunez, Perez A, Lagares, A, Perez, Garcia D, Santas, M, Paredes, I, Sinovas, Esteban O, Moreno-Gomez, L, Rubio, E, Vega, V, Lopez, Vivas A, Martinez, Labalde M, Villar, Garcia O, Pelaez Torres, PM, Garcia, Borda, J, Herrero, Ferrero E, Gomez, P, Fernandez, Eiriz C, Ojeda-Thies, C, Garcia, Pardo JM, Di Martino, M, De la Hoz Rodriguez, A, Garcia Septiem, J, Maqueda Gonzalez, R, Delgado Burdalo, L, Correa Bonito, A, Martin-Perez, E, Villayzan, Garcia JE, Martin, Albi B, Lominchar, Lozano P, Martin, L, Fernadez, M, Rey-Valcarcel, C, Tousidonis, M, Caballero, Martin-Albo L, Lowy, A, Ortuno, Alonso P, Herrera, Ayuso E, Velasco, Cano J, Aragon-Chamizo, J, Diaz, Perez MD, Mateo-Sierra, O, Quintana-Villamandos, B, Barrio, JM, Fanjul, M, Sanchez-Perez, C, Fernandez, ML, Hernandez-Kakauridze, S, Rio, J, Perez, Diaz D, Gonzalez, Serrano J, Garcia, Colao L, Samaniego, Gutierrez M, Bartolome, Hernandez MA, Jara, Galindo P, Agusti, Esteban E, Ripolles-Melchor, J, Abad-Motos, A, Abad-Gurumeta, A, Martinez-Hurtado, E, Ruiz-Escobar, A, Brogly, N, Guasch, E, Gutierrez, Hernandez A, Rasero, Bartha JL, Perez, Y, Garcia-Pineda, V, Gracia, M, Ridruejo, Siegrist J, Diestro, MD, Sanchez-Mendez, JI, Marti, C, Melendez, M, Moreno-Palacios, E, Loayza, A, Frias, L, Zapardiel, I, Rubio-Perez, I, Nieto, Prieto MI, Guevara, J, Simon, Gegundez A, GortazarS, Chavarrias, N, Alvarez, E, Saavedra, J, Ramos-Martin, P, Urbieta, A, Rivas, Gomez J, Toribio-Vazquez, C, Yebes, A, Hernandez-Garcia, M, Losada, M, Dieguez, B, Garcia-Conde, M, Poza, Alonso A, Marquez, L, Becerra, R, Martin, M, Jorgensen, T, Muguerza, JM, Dziakova, J, del Pueblo, Sanchez C, Carlin, Saez P, Camarero, E, Picazo, S, Pizarro, MJ, Avellana, R, Catalan, V, Antonanzas, Lopez L, Cano, O, Anula, R, Lopez, Sanz R, Ortega, Sanz G, Alonso, Garcia M, Torres, AJ, Antona, Martin E, Botella, Garcia S, Ramos, D, Barranquero, AG, Ocana, J, Nunez, J, Zaballos, Cerro C, Crego-Vita, D, Huecas-Martinez, M, Alonso, Diez M, Mendoza-Moreno, F, Mansilla, Vera C, Merino, Ovejero E, Hernandez, P, Martin, Blazquez A, Grande, Ruiz F, Palacios, Morales N, Gomez, Garcia-Loarte E, Rico, Garca E, Minaya-Bravo, AM, Mendez, San Miguel C, Perez, Galvan A, Gonzalez-Gonzalez, E, Valle de Lersundi, Robin A, Calcerrada Alises, E, Garcia-Urena, MA, Cruz Cidoncha, A, Troncoso Pereira, P, Alcaide Matas, F, Garcia Perez, JM, Munoz Vives, JM, Osorio, A, Gomez Diaz, CJ, Guariglia, CA, Soto Montesinos, C, Sanchon, L, Xicola Martinez, M, Guardia, N, Collera, P, Diaz Del Gobbo, R, Sanchez Jimenez, R, Farre Font, R, Flores Clotet, R, Calvo Espino, P, Guillamot Ruano, P, Rey-Biel, J, Pingarron-Martin, L, Ruiz Martin, I, Moliner Sanchez, C, Carrasco-Prats, M, Gimenez-Frances, C, Ruiz-Marin, M, Fernandez-Lopez, AJ, Garcia-Escudero, D, Garcia-Porcel, V, Lax-Perez, R, Sanchez-Robles, M, Valero-Soriano, M, Medina-Manuel, E, Garcia-Soria, V, Gurrea-Almela, E, Marco-Garrido, A, Martinez-Alonso, JA, Gonzalez-Valverde, FM, Fernandez-Fernandez, PV, Sanchez-Rodriguez, C, Aguilar-Jimenez, J, Baeza-Murcia, M, Aguayo-Albasini, JL, Nicolas-Lopez, T, Alconchel, F, Fernandez Martinez, D, Solar-Garcia, L, Garcia Florez, LJ, Llaquet Bayo, H, Pujol-Cano, N, Segura-Sampedro, JJ, Soldevila-Verdeguer, C, Jeri-McFarlane, S, Gil-Catalan, A, Craus-Miguel, A, Cruz, L, Valente, P, Afonso-Garcia, M, Ferrer-Inaebnit, E, Oseira-Reigosa, A, Fernandez-Vega, L, Villalonga-Ramirez, B, Gonzalez Argente, FX, Mora-Guzman, I, Landete Molina, FJ, Morera Ocon, FJ, Canelles Corell, E, Gavalda Pellice, MT, Salinas Pena, JR, Cavalle Busquets, P, Trebol, J, Sanchez-Casado, AB, Munoz-Bellvis, L, Perez-Sanchez, LE, Concepcion Martin, V, Diaz Garcia, A, Vallve-Bernal, M, Calvo Rey, A, Prada Hervella, GM, Dos Santos Carregal, L, Rodriguez, Fernandez MI, Freijeiro, M, El Drubi, Vega S, Picardo, AL, Cuadrado-Garcia, A, Serralta de Colsa, D, Rojo Lopez, JA, Cabezudo Noguera, Sanchez F, Ortega Vazquez, I, Garcia-Sancho Tellez, L, Mato, P, Heras Aznar, J, Jimeno Fraile, J, Morales-Garcia, D, Carrillo-Rivas, M, Toledo Martinez, E, Pascual, A, Senent-Boza, A, Sanchez-Arteaga, A, Benitez-Linero, I, Manresa-Manresa, F, Tallon-Aguilar, L, Melero-Cortes, L, Fernandez-Marin, MR, Duran-Munoz-Cruzado, VM, Ramallo-Solis, I, Beltran-Miranda, P, Pareja-Ciuro, F, Anton-Eguia, BT, Mompean, Oliva F, Gomez-Rosado, J, Reguera-Rosal, J, Valdes-Hernandez, J, Capitan-Morales, L, Achalandabaso Boira, M, Ikuga, Memba R, Abellan, M, Sales, R, Olona, C, Jorba, R, Hernandez Gutierrez, J, Tebar Zamora, A, Sancho-Muriel, J, Cholewa, H, Frasson, M, Domenech, J, Anon, Rosello A, Sanguesa, MJ, Moro-Valdezate, D, Garces-Albir, M, Lopez, F, Bernal-Sprekelsen, JC, Catala Bauset, JC, Renovell Ferrer, P, Martinez Perez, C, Gil-Albarova, O, Estelles, Gilabert J, Aghababyan, K, De Andres-Asenjo, B, de Heredia, Beltran J, Vazquez-Fernandez, A, Ortiz De Solorzano-Aurusa, FJ, Trujillo-Diaz, J, Ruiz-Soriano, M, Jezieniecki, C, Gomez-Sanz, T, Nunez-Del Barrio, H, Romero-De Diego, A, Garcia-Virto, V, Aguado, HJ, Fernandez Martin, MT, Tejero-Pintor, FJ, Perez-Saborido, B, Bhojwani, Choolani E, Garcia, Acebes F, Marcos-Santos, P, Bueno Canones, AD, Sanchez Gonzalez, J, Toledano, M, Bailon, M, Pacheco Sanchez, D, Garcia Senorans, Paniagua M, Sanchez-Santos, R, Vazquez Melero, A, Garcia, D, Diez, E, Herrero, I, Soeda, IM, Camuera, M, Balluerca, M, Sanchez-Rubio, M, Paunero Vazquez, P, Martinez-German, A, Gracia-Roche, C, Gascon-Ferrer, I, Duque-Mallen, V, De Miguel-Ardevines, MDC, Sanchez-Fuentes, N, Santero-Ramirez, MS, Matute-Najarro, M, Herrero-Lopez, M, Cantalejo-Diaz, M, Gonzalez-Nicolas-Trebol, MT, Saudi-Moro, S, Jariod-Ferrer, UM, Rivas, F, Escartin, J, Laina, Blas JL, Nogues, A, Cros, B, El-Abur, Talal I, Egea, Garcia J, Yanez, C, Jayarajah, U, Ravindrakumar, S, Rodrigo, VSD, Arulanantham, A, Gb, Bandara KD, Hamid, HKS, Ali, EE, Widatalla, ABH, Bakheit, I, Awadelkarim, M, Karar, Ali AA, Saleh, M, Taflin, H, Myrelid, P, Braz, Amorim L, Hagander, L, Hambraeus, M, Omling, E, Salo, M, Arkani, S, Freedman, J, Montan, C, Lindqvist, EK, Elbe, P, Hultgren, R, Nordberg, M, Sandblom, G, Rutegard, M, Holmner, F, Sund, M, Lofgren, N, Tampakis, A, Kollmar, O, Balaphas, A, Toso, C, Colucci, N, Popeskou, SG, Gass, M, Scheiwiller, A, Metzger, J, Gialamas, E, Chevallay, M, Sauvain, M, Dwidar, O, Kiessling, SY, Stoeckli, SJ, Mongelli, F, Bernasconi, M, Di Giuseppe, M, Christoforidis, D, La Regina, D, Arigoni, M, Adamina, M, Peros, G, Guglielmetti, L, Solimene, F, Giardini, M, Bachler, T, Crugnale, AS, Gutschow, CA, Turina, M, Ersen, O, Onan, MA, Kozan, R, Erol, T, Dincer, HA, Yildiz, A, Iflazoglu, N, Isik, A, Ozben, V, Aytac, E, Aliyeva, Z, Akaydin, E, Ozmen, BB, Baca, B, Altinel, Y, Calikoglu, F, Tokocin, M, Hacim, NA, Akbas, A, Meric, S, Vartanoglu, T, Yigitbas, H, Ercetin, C, Ercan, G, Ozgur, I, Keskin, M, Saracoglu, KT, Cimenoglu, B, Demirhan, R, Kale, A, Simsek, T, Gundogdu, EC, Abbasov, A, Tanal, M, Citgez, B, Bozkurt, E, Yetkin, SG, Mihmanli, M, Alhamed, A, Ergun, S, Sanli, AN, Velidedeoglu, M, OZcelik, KMF, Uludag, SS, Zengin, AK, Cebi, S, Demirkiran, F, Bese, T, Acikgoz, AS, Kayan, B, Aykanat, Y, Mutlu, D, Goksoy, B, Kara, Y, Bozkurt, MA, Uslu, G, Arican, C, Tugmen, C, Aydin, C, Yesilyurt, D, Avci, EK, Kilinc, G, Tuncer, K, Akalin, M, Emiroglu, M, Atici, Demirli S, Kaya, T, Kirmizi, Y, Tatar, OC, Yuksel, E, Sa, Guler, Yildirim, A, Utkan, NZ, Gozal, K, Koken, H, Yabas, A, Gonullu, E, Altintoprak, F, Akin, E, Kamburoglu, B, Capoglu, R, Kucuk, F, Demir, H, Cakmak, G, Firat, N, Celebi, F, Kocer, B, Mantoglu, B, Bayhan, Z, Dikicier, E, Colak, E, Kucuk, GO, Karaman, E, KolusabA, Karaaslan, O, Majid, I, Alshryda, S, Abbas, F, Abbas, FMA, Mohammed, D, Tahlak, MA, Yammahi, A, Albaroudi, AA, Elyafawi, B, Saber, A, Khansaheb, H, Alsaadi, H, Alzarooni, N, Bekheit, M, Kamera, BS, Elhusseini, M, Sharma, P, Ahmeidat, A, Gradinariu, G, Cymes, W, Hannah, A, Mignot, G, Shaikh, S, Agilinko, J, Angelou, D, Neely, D, McCanny, A, McAree, B, Baldwin, AJ, West, R, Gammeri, E, Catton, A, Kouris, Marinos S, Pereca, J, Singh, J, Seymour, Z, Jones, R, Leeson, S, Peevor, R, Lala, AK, Houlden, C, Kahiu, J, Hossain, N, Hosny, S, Patel, P, Handa, S, Kaushal, M, Kler, A, Reghuram, V, Tezas, S, Fairhurst, K, Yates, C, Mitchell, S, Bunni, J, Richards, S, George, R, Lee, SM, Phull, J, Frost, J, Burnard, S, Crowley, R, Airey, A, Bevan, K, Makin-Taylor, R, Ong, CS, Callan, R, Bloom, O, Aljanadi, F, Moawad, N, Jones, M, Gregg, A, Jeganathan, R, Pachl, M, Martin, B, Archer, JE, Odeh, A, Siddaiah, N, Singhal, R, Naumann, DN, Karandikar, S, Syed, A, Tucker, ON, Alam, R, Kalkat, M, Mak, JKC, Kulkarni, R, Sharma, N, Nankivell, P, Tirotta, F, Parente, A, Breik, O, Kisiel, A, Cato, LD, Saeed, S, Griffiths, E, Pathanki, AM, Ford, S, Desai, A, Almond, M, Kamal, M, Sundar, S, Leung, EYL, Kaur, R, Brett-Miller, C, Buruiana, FE, Markose, G, Rico, De Gea A, Taib, A, Myatt, D, Khaled, Sulaiman A, Younis, F, Sultana, A, Taggarsi, M, Vitone, L, Lambert, J, Vaz, OP, Sarantitis, I, Shrestha, D, Timbrell, S, Shugaba, A, Quddus, B, Law, J, Bittar, MN, Creanga, M, Elniel, M, Youssef, M, Ali, S, Qadri, ST, Brixton, G, Findlay, L, Majkowska, Klatte TA, Manson, J, Potter, R, Oktseloglou, V, Mosley, F, Monroy, De La Cruz MFI, Bobak, P, Omar, I, Ahad, S, Langlands, F, Brown, V, Hashem, M, Kennedy, L, Jaunoo, S, Coomber, E, Williams, O, Rhodes, HL, Williams, A, Ridgway, A, Pournaras, D, Britton, E, Lostis, E, Ambler, GK, Chu, H, Hopkins, J, Manara, J, Chan, M, Doe, M, Moon, RDC, Lawday, S, Jichi, T, Singleton, W, Main, B, Maccabe, T, Newton, C, Blencowe, NS, Fudulu, DP, Bhojwani, D, Baquedano, M, Caputo, M, Rapetto, F, Flannery, O, Hassan, A, Coonar, A, Aresu, G, Smith, C, Gearon, D, Hogan, J, Pradeep, IS, Durio Yates, H, Peryt, A, Barrett-Brown, ZM, King, M, Ahmadi, N, Jenkins, D, Moorjani, N, Taghavi, F, Wells, F, Hardie, J, Page, S, Anazor, F, King, SD, Luck, J, Kazzaz, S, Mannion, R, Stewart, GD, Ramzi, J, Mohan, M, Singh, AA, Ashcroft, J, Baker, OJ, Coughlin, P, Davies, RJ, Durst, AZED, Abood, A, Habeeb, A, Hudson, VE, Kolias, A, Lamb, B, Luke, L, Mitrasinovic, S, Murphy, S, Ngu, AWT, O'Neill, JR, Waseem, S, Wong, K, Georgiades, F, Hutchinson, PJ, Tan, XS, Pushpa-rajah, J, Colquhoun, A, Masterson, L, Abu-Nayla, I, Walker, C, Balakrishnan, A, Rooney, S, Irune, E, Byrne, MHV, Durrani, A, Simoes, A, Eddy, B, Streeter, E, Ahmed, I, Yao, M, Wang, W, Djouani, A, Tait-Bailey, J, Thomas, M, Hassan, F, Kommu, S, Chopra, S, Richards, T, Venkatesan, Sethuraman A, Combellack, T, Williams, J, Tahhan, G, Mohammed, M, Kornaszewska, M, Valtzoglou, V, Deglurkar, I, Rahman, M, Von Oppell, U, Mehta, D, Koutentakis, M, Chek, Syed Nong SAH, Hill, G, Morris, C, Shinkwin, M, Torkington, J, Cornish, J, Houston, R, Mannan, S, Ayeni, F, Tustin, H, Bordenave, M, Robson, A, Dovell, G, Preece, R, Rolland, P, Miranda, BH, Sobti, A, Khaleel, A, Unnithan, A, Memon, K, Bhaskar, Pala RR, Maqboul, F, Kamel, F, Al-Samaraee, A, Madani, R, Kumar, L, Nisar, P, Agrawal, S, Vimalachandran, D, Manu, N, Eardley, N, Krishnan, E, Serevina, OL, Martin, E, Jones, A, Mahapatra, Roy S, Clifford, R, Jones, GP, Gardner, A, Tripathi, SS, Greenhalgh, MS, Matthews, W, Mohankumar, K, Khawaja, I, Palepa, A, Doulias, T, Gill, C, Dunne, N, Sarma, DR, Godbole, C, Carlos, W, Tewari, N, Jeevan, D, Naredla, P, Khajuria, A, Connolly, H, Robertson, S, Sweeney, C, Di Taranto, G, Shanbhag, S, Dickson, K, McEvoy, K, Skillman, J, Sait, M, Al-omishy, H, Baig, M, Heer, B, Brown, A, Ebrahim, A, Alwadiya, A, Goyal, A, Phillips, A, Bhalla, A, Demetriou, C, Grimley, E, Theophilidou, E, Ogden, E, Malcolm, FL, Davies-Jones, G, Ng, JCK, Mirza, M, Hassan, M, Elmaleh, N, Daliya, P, Williams, S, Bateman, A, Chia, Z, Premakumar, Y, Jauhari, Y, Koshnow, Z, Bowen, D, Uberai, A, Hirri, F, Stubbs, BM, Crichton, R, Sonksen, J, Aldridge, K, McDonald, C, Manickavasagam, J, Ragupathy, K, Davison, S, Dalgleish, S, McGrath, N, Kanitkar, R, Payne, CJ, Ramsay, L, Ng, CE, Collier, T, Khan, K, Evans, R, Brennan, C, Henshall, DE, Drake, T, Harrison, EM, Zamvar, V, Tambyraja, A, Skipworth, RJE, Linder, G, McGregor, R, Brennan, P, Mayes, J, Ross, L, Smith, S, White, T, Jamjoom, AAB, Pasricha, R, Gallagher, K, Swan, R, Paterson, H, Maeda, Y, Kwok, AMF, Tsiaousidou, A, Vaughan-Shaw, PG, Boyle, C, Fernando, D, Tham, D, Leung, S, Laird, A, Holme, T, Abbott, S, Razik, A, Thrumurthy, S, Steinke, J, Baker, M, Howden, D, Baxter, Z, Osagie, L, Bence, M, Fowler, GE, Massey, L, Rajaretnam, N, Evans, J, John, J, Goubran, A, Campain, N, McDermott, FD, McGrath, JS, Ng, M, Pascoe, J, Phillips, JRA, Daniels, IR, ACourt, J, Konarski, A, Faulkner, G, Emerson, H, Vejsbjerg, K, Pearce, L, McCormick, W, Fisher, A, Singisetti, K, Aawsaj, Y, Bajomo, O, Rizvi, S, Grimes, C, Dusu, K, Tint, PY, Kirk, A, Irvine, V, Lammy, S, OKane, R, Elliott, L, Mccabe, G, Holroyd, D, Jamieson, NB, Geddes, A, McMahon, J, McCaul, J, Al-Azzawi, M, Aitken, E, Glen, P, Sinan, LOH, Grivas, A, Tilling, EJ, Brown, O, Boal, M, Dean, H, Higgs, S, Stanger, S, Abdalaziz, H, Constable, J, Ishii, H, Reddy, Gopi R, Madhuri, TK, Tailor, A, Flavin, M, Walker, D, Humphries, S, Assalaarachchi, H, Curl-Roper, T, Westwood, E, Delimpalta, C, Liao, CCL, Velchuru, V, Raptis, DA, Pollok, JM, Machairas, N, Davidson, B, Fusai, G, Soggiu, F, Xyda, S, Salinas, Hidalgo C, Tzerbinis, H, Pissanou, T, Gilliland, J, Varcada, M, Hart, C, Mirnezami, R, Knowles, J, Angamuthu, N, Vijay, V, Shakir, T, Hasan, R, Tansey, R, Hardie, C, Powell-Smith, E, Kashora, F, Siddique, MH, Singh, A, Barmpagianni, C, Basgaran, A, Basha, A, Okechukwu, V, Bartsch, A, Gallagher, P, Maqsood, A, Sahnan, K, Leo, CA, Lewis, SE, Ubhi, HK, Exley, R, Khan, U, Shah, P, Saxena, S, Zafar, N, Abdul-Jabar, H, Patel, M, Shabana, A, Alanbuki, A, Usman, O, Ong, CT, Butterworth, W, Magar, Budha O, El Hadi, M, Abas, S, Annett, J, Ross, E, Loubani, M, Wilkins, A, Cao, H, Capitelli-McMahon, H, Hitchman, L, Ikram, H, Andronic, A, Ibrahim, Aboelkassem A, Totty, J, Blanco, J, Vanker, R, Ghobrial, M, Jones, G, Kanthasamy, S, Fawi, H, Awadallah, M, Chen, F, Cheung, J, Moscalu, A, Bhuvanakrishna, T, Bibby, L, Sinclair, M, Nahid, MAK, Williams, L, Basnyat, PS, Shrestha, AK, Kumaran, NK, Sambhwani, S, Sheikh, NA, Taylor, OM, Liew, I, Al-Sukaini, A, Mediratta, S, Saxena, D, Sgro, A, Rashid, MM, Milne, K, McIntyre, J, Akhtar, MA, Turnbull, A, Brunt, A, Stewart, KE, Wilson, MSJ, Rutherford, D, McGivern, K, Massie, E, Ho, M, Wade, RG, Johnstone, J, Bourke, G, Brunelli, A, Elkadi, H, Otify, M, Pompili, C, Burke, JR, Bagouri, E, Chowdhury, M, Abual-Rub, Z, Kaufmann, A, Munot, S, Lo, T, Young, A, Kowal, M, Wall, J, Peckham-Cooper, A, Layton, GR, Karki, B, Jeong, H, Pankhania, S, Asher, S, Folorunso, A, Mistry, S, Singh, B, Winyard, J, Mangwani, J, Caruana, EJ, Mohammad, A, Acharya, M, Chandarana, K, Ang, K, Chowdhry, MF, Rathinam, S, Nakas, A, Boddy, A, Hossain, T, Ashmore, C, Annamalai, S, Kourdouli, A, Irvine, E, Al-Harbawi, A, Kassam, K, Al-Harbawee, A, Miller, A, Mair, M, Lunevicius, R, Sheel, ARG, Sundhu, M, Santini, AJA, Fathelbab, MSAT, Hussein, KMA, Nunes, QM, Jones, RP, Shahzad, K, Haq, I, Baig, MMAS, Hughes, JL, Kattakayam, A, Rajput, K, Misra, N, Shah, SB, Clynch, AL, Georgopoulou, N, Sharples, HM, Apampa, AA, Nzenwa, IC, Sud, A, Harky, A, Kirmani, BH, Shackcloth, M, Jenkinson, MD, Zakaria, R, Elmoslemany, T, Millward, CP, Baron, R, Dunne, D, Szatmary, P, Thomas, A, McNicol, F, Gahunia, S, Sochorova, D, Nita, GE, McKinney, R, Russ, J, Tan, JR, Harwood, R, Corbett, HJ, Rossborough, C, Skelly, BL, Bakri, Che NA, Nazarian, S, Vashisht, R, Jiao, L, Jawad, Z, Allan, AY, Kontovounisios, C, Grove, T, Warren, O, Fadel, MG, Chatzikonstantinou, M, Sorelli, P, Rahman, S, Hadjipavlou, M, Holbrook, C, Chong, C, Kufeji, D, Rufai, SR, Lloyd, IC, James, G, Chari, A, Silva, AHD, Stroman, L, Challacombe, B, Sayasneh, A, Najdy, M, Bille, A, Fraser, S, Agoston, P, Rizzo, V, King, J, Nath, R, Sarah, McCrindle, Mehra, G, Harrison-Phipps, K, Pilling, J, Okiror, L, Routledge, T, Mills, L, Wali, A, El-Boghdadly, K, Fotopoulou, C, Saso, S, Fehervari, M, Ploski, J, Ghaem-Maghami, S, Spalding, D, Rajagopal, P, Pai, M, Habib, N, Hamrang-Yousefi, S, Tayeh, S, Chase, T, Humphreys, L, Ayorinde, J, Ghanbari, A, Cuming, T, Anscomb, N, Baldwin-Smith, R, Rizk, M, Grainger, C, Davies, M, Surendran, A, Nunoo-Mensah, JW, Dunstan, M, Beak, P, Gerogiannis, I, Jain, A, Menon, A, Pramodana, B, Choi, D, Marcus, HJ, Webber, L, May, R, Hutchison, R, Luoma, V, Ranjit, S, Parakh, J, Sarodaya, V, Daadipour, A, Khalifa, M, Bosch, KD, Bashkirova, V, Dvorkin, LS, Kalidindi, VK, Dudek, J, Singhal, T, El-Hasani, S, De Souza, A, Cannoletta, M, Rochon, M, Bhudia, S, Bennett, S, Navaratne, L, Venn, M, Yip, V, Kayani, B, Sohrabi, C, Kocher, HM, Minicozzi, A, Banerjee, A, Sullivan, T, Sivaprakasam, R, Anzak, A, Ghufoor, K, Thaha, MA, Knowles, C, Ledesma, FS, Patki, P, Popova, D, Sadigh, P, Ramamoorthy, R, Uff, C, Attwell, L, Tanabalan, C, Goh, MA, Jayasinghe, JD, Silva, Leal I, Thakur, B, Lebe, M, Thet, MS, Hughes, F, Rahman, R, Fuwa, O, Sanders, J, Oo, A, Bueser, T, Curtis, M, Stamenkovic, SA, Abbott, T, Anwar, S, Williams, K, Chung, E, Hagger, R, Karim, A, Hainsworth, A, Flatman, M, Trompeter, A, Hing, C, Tsinaslanidis, P, Benjamin, MW, Leyte, A, Tan, C, Smelt, J, Vaughan, P, Santhirakumaran, G, Hunt, I, Raza, M, Labib, A, Luo, X, Sudarsanam, A, Rolls, A, Lyons, O, Onida, S, Shalhoub, J, Sugand, K, Park, C, Sarraf, KM, Erridge, S, Kinross, J, Denning, M, Yalamanchili, S, Abuown, A, Ibrahim, M, Martin, G, Davenport, D, Wheatstone, S, Kasivisvanathan, V, Kapriniotis, K, Elhamshary, A, Imam, SMB, Kalavrezos, N, Sinha, D, Green, Chand ML, Beech, N, McEwen, R, Kiconco, H, Andreani, SM, Bath, MF, Sahni, A, Judkins, N, Springford, Rigueros L, Bacarese-Hamilton, J, Taylor, FG, Parmar, C, Mccluney, S, Shah, S, Talwar, R, Patel, K, Askari, A, Jambulingam, PS, Shaw, S, Maity, A, Hatzantonis, C, Sagar, J, Kudchadkar, S, Cirocchi, N, Chan, CH, Reynolds, J, Alexander, ME, Smart, CJ, Jayasankar, B, Balasubramaniam, D, Abdelsaid, K, Mundkur, N, Gallagher, B, Shah, J, Anthoney, J, Emmerson, O, Stylianides, N, Abdalla, M, Newton, K, Bhatia, K, Edmondson, R, Abdeh, L, Jones, D, Zeiton, M, Ismail, O, Naseem, H, Advani, R, Duff, S, Moura, F, Brown, BC, Khan, A, Asaad, P, Wadham, B, Aneke, IA, Collis, J, Warburton, H, Fell, A, Smith, A, Halkias, C, Nikolaou, S, English, C, Kristinsson, S, Oni, T, Ilahi, N, Ballantyne, K, Woodward, Z, Merh, R, Dunning, J, Viswanath, Y, Freystaetter, K, Dixon, J, Hadfield, JN, Hilley, A, Egglestone, A, Smith, B, Hine, T, Keeler, B, Soulsby, RE, Taylor, A, Davies, E, Ryska, O, Raymond, T, Rogers, S, Tong, A, Hawkin, P, Tingle, S, Abbadessa, F, Sachdeva, A, Rai, B, Chan, CD, McPherson, I, Booth, K, Ali, Mahmoud F, Pandanaboyana, S, Grainger, T, Nandhra, S, Patience, A, Roy, C, Williams, T, Dawe, N, McCaffer, C, Riches, J, Bhattacharya, S, Moir, J, Kalson, NS, Ahmed, Elamin H, Mellor, C, Saleh, C, Koshy, RM, Hammond, J, Sanderson, L, Wahed, S, Phillips, AW, Ghosh, K, Tang, A, Beamish, AJ, Price, C, Bosanquet, D, Magowan, D, Solari, F, Williams, G, Nassa, H, Smith, L, Robertson-Smith, B, Mahmoud, A, Ameerally, P, Finch, JG, Gnanachandran, C, Pop, I, Rogers, M, Yousef, Y, Mohamed, I, Woods, R, Zahid, H, Mundy, G, Sreedharan, L, Baskaran, D, Shaikh, I, Seebah, K, Reid, J, Watts, D, Kouritas, V, Chrastek, D, Maryan, G, Gill, DF, Khatun, F, Gajjar, K, Williamson, K, Bratt, D, Konstantinidi, K, Walton, T, Burnside, N, Weaver, H, Hawari, M, Addae-Boateng, E, Rollett, RA, Collins, ML, Tamimy, MS, Riyat, H, Wen, J, Neil-Dwyer, J, Brewer, H, Humes, D, Worku, D, Chowdhury, A, Oyende, O, Lewis-Lloyd, C, Adiamah, A, Koh, A, Jackman, J, Vohra, R, Navarro, A, Reilly, J, Aujayeb, A, Townshend, D, McLarty, N, Shenfine, A, Jackson, K, Johnson, C, Dass, D, Ford, D, Winter, SC, Belcher, E, Stavroulias, D, Di Chiara, F, Wallwork, K, Qureishi, A, Lami, M, Sravanam, S, Mastoridis, S, Shah, K, Chidambaram, S, Smillie, R, Shaw, AV, Bandyopadhyay, S, Cernei, C, Bretherton, C, Jeyaretna, D, Ganau, M, Piper, RJ, Duck, E, Brown, S, Jelley, C, Tucker, SC, Bond-Smith, G, Griffin, XL, Tebala, GD, Neal, N, Vatish, M, Noton, TM, Ghattaura, H, Maher, M, Fu, H, Risk, OBF, Majd, Soleymani H, Sinha, S, Shankar, S, Aggarwal, A, Khatkar, H, Lakhoo, K, Verberne, C, Dean, B, Luney, C, Myatt, R, Williams, MA, McVeigh, J, Rogers, LJ, Labib, PL, Miller, D, Minto, G, Hope, N, Marchbank, A, Emslie, K, Panahi, P, Ho, B, Perkins, C, Clough, E, Roy, H, Enemosah, I, Campbell, R, Natale, J, Gohil, K, Rela, M, Raza, N, Biliatis, I, Khan, J, Thiruchandran, G, Toh, SKC, Ahmad, Y, Allana, A, Bellis, C, Babawale, O, Phan, YC, Lokman, U, Ismail, M, Koc, T, Witek, A, Duggleby, L, Shamoon, S, Stefan, S, Clancy, H, Chadha, R, Middleton, SB, Wilmott, K, Hayden, C, Mclaren, C, Sutton, J, Whyte, A, Belgaumkar, A, Day, A, Gilbert, C, Oyewole, B, Narayan, P, Dent, H, Sandhya, A, De Silva, T, Waheed, S, Kapoor, K, Belgaumkar, AP, Fahim, M, Gala, T, Mithany, R, Morgan, R, Abdelkarim, M, Maw, A, Asqalan, A, Venkatesan, Sundaram G, Singh, S, Mukherjee, S, Ferguson, D, Mansuri, A, Thakrar, A, Wickramarachchi, L, Cuthbert, R, Sivayoganathan, S, Chui, K, Karam, E, Dott, C, Madhvani, K, Hampton, M, Hormis, AP, Fountain, DM, Laurente, R, Sigamoney, KV, Dasa, M, George, K, Naqui, Z, Galhoum, M, Lipede, C, Gabr, A, Radhakrishnan, A, Hasan, MT, Kalenderov, R, Pathmanaban, O, Chelva, R, Branagan, G, Longstaff, L, Ding, D, Barlow, C, Foster, J, Edwards, J, Ward, A, Tadross, D, Majkowski, L, Blundell, C, Forlani, S, Nair, R, Guha, S, Brown, SR, Steele, C, Kelty, CJ, Newman, T, Lee, M, Chetty, G, Lye, G, Balasubramanian, SP, Shah, Sureshkumar N, Sherif, M, Al-mukhtar, A, Whitehall, E, Giblin, A, Sharkey, A, Adamec, A, Madan, S, Narice, B, Sterrenburg, M, Thompson, A, Varley, I, Stavrakas, M, Rominiyi, O, Ray, J, Crank, M, Bacon, A, Al-Tamimi, Y, Catto, J, Saad, S, Abd Kahar, NN, Sou, A, Simpson, D, Hamilton, E, Blair, J, Jallad, S, Lord, J, Anderson, C, El Kafsi, J, Logishetty, K, Saadya, A, Midha, R, Ip, M, Ponniah, Subbiah H, Stockdale, T, Bacarese-Hamilton, T, Foster, L, James, A, Anjarwalla, N, Henriques, Marujo D, Hettige, R, Baban, C, Tenovici, A, Salerno, G, Lane, J, Colvin, HV, Badran, A, Cadersa, A, Cumpstey, A, Hamady, Z, Aftab, R, Wensley, F, Byrne, J, Morrison-Jones, V, Sekhon, GK, Shields, H, Shakoor, Z, Yener, A, Talbot, T, Alzetani, A, Cresner, R, Babu, BHB, Liyanage, ASD, Newman, S, Blake, I, Weerasinghe, C, Baumber, R, Parry, J, Menakaya, C, Webb, JI, Antar, M, Modi, N, Sofat, R, Noel, J, Nunn, R, Adegbola, S, Eriberto, F, Sharma, V, Tanna, R, Lodhia, S, Johnson, D, Hughes, I, Hall, J, Rooney, J, Chatterji, S, Zhang, Y, Owen, R, Rudic, M, Hunt, J, Zakai, D, Aladeojebi, A, Ali, M, Gaunt, A, Barmayehvar, B, Kitchen, M, Gowda, M, Mansour, F, Jarvis, M, Halliday, E, Lefroy, R, Nanjaiah, P, Lin, DJ, Rajgor, AD, Scurrah, RJ, Kang, C, Watson, LJ, Harris, G, Royle, T, Cunningham, Y, Steel, B, Luk, ACO, Boulton, AJ, Khan, T, Bakolas, G, Herrod, P, Gemmill, E, Boyd-Carson, H, Jibreel, M, Lenzi, E, Saafan, T, Sapre, D, Li, Z, Parkins, K, Spencer, N, Harries, R, Egan, RJ, Motter, D, Jenvey, C, Mahoney, R, Fine, N, Minto, T, Henry, A, Hollyman, M, Grieco, C, Gemmell, C, Whitmore, H, Babar, MS, Goodrum, S, Scott, R, Collard, B, Lau, K, Thomas, E, Patel, A, Allison, J, Bowen, J, Dias, A, Mahendran, B, Gopalswamy, S, Patil, S, Scott, L, Sarveswaran, J, Michel, M, Ravindran, S, Subba, K, Abou-Foul, AK, Khalefa, M, Hossain, F, Moores, T, Pickering, L, Stables, G, Doorgakant, A, Thiruvasagam, VG, Carter, J, Reid, S, Mohammed, R, Marlow, W, Ferguson, H, Wilkin, R, Konstantinou, C, Yershov, D, Vatish, J, Denning, A, Shah, HB, Cross, GWV, Seyed-Safi, P, Smart, YW, Kuc, A, Al-Yaseen, M, Olivier, J, Hanna, M, Eskander, P, Duncan, R, Halaseh, S, Das, R, Jones, Wynn H, Divecha, H, Whelton, C, Board, T, Powell, S, Magee, C, Agarwal, K, Mangos, E, Nambirajan, T, Vidya, R, Chauhan, G, Kaur, J, Burahee, A, Bleibleh, S, Pigadas, N, Snee, D, Bhasin, S, Crichton, A, Habeebullah, A, Bodla, AS, Yassin, N, Mondragon, M, Dewan, V, Flindall, I, Mahendran, V, Hanson, A, Jenner, E, Richards, J, Thomas-Fernandez, K, Wall, R, Alqallaf, A, Ben-Sassi, A, Mellor, K, Joshi, P, Joshi, Y, Young, R, Miu, V, Sheridan, K, MacDonald, L, Green, S, Onos, L, Wong, JJ, Napolitano, L, Hemmila, M, Amin, D, Abramowicz, S, Roser, SM, Olson, KA, Riley, C, Heron, C, Cardenas, T, Leede, E, Thornhill, M, Haynes, AB, McElhinney, K, Roward, S, Trust, MD, Hill, CE, Teixeira, PG, Etchill, E, Stevens, K, Ladd, MR, Long, C, Rose, J, Kent, A, Yesantharao, P, Vervoort, D, Jenny, H, Gabre-Kidan, A, Margalit, A, Tsai, L, Malapati, H, Yesantharao, L, Abdou, H, Diaz, J, Richmond, M, Clark, J, OMeara, L, Hanna, N, Ying, Y, Fleming, J, Ovaitt, A, Gigliotti, J, Fuson, A, Cooper, Z, Salim, A, Hirji, SA, Chung, C, Hansen, L, Okafor, BU, Roxo, V, Raut, CP, Jolissaint, JS, Mahvi, DA, Kaafarani, H, Breen, K, Bankhead-Kendall, B, Alser, O, Mashbari, H, Velmahos, G, Maurer, LR, El Moheb, M, Gaitanidis, A, Naar, L, Christensen, MA, Kapoen, C, Langeveld, K, El Hechi, M, Mokhtari, A, Haqqani, MH, Drake, FT, Goldenberg-Sandau, A, Galbreath, B, Reinke, C, Ross, S, Thompson, K, Manning, D, Perkins, R, Evans, H, Masrur, M, Giulianotti, P, Benedetti, E, Chang, G, Ourieff, J, Dehart, D, Dorafshar, A, Price, T, Bhama, AR, Torquati, A, Cherullo, E, Kennedy, R, Myers, J, Rubin, K, Ban, VS, Aoun, SG, Batjer, HH, Caruso, J, Carmichael, H, Velopulos, CG, Wright, FL, Urban, S, McIntyre, Jr RC Jr, Schroeppel, TJ, Hennessy, EA, Dunn, J, Zier, L, Burlew, C, Coleman, J, Colling, KP, Hall, B, Rice, HE, Hwang, ES, Olson, SA, Moris, D, Verma, R, Hassan, R, Volpe, A, Merola, S, OBanion, LA, Lilienstein, J, Dirks, R, Marwan, H, Almasri, M, Kulkarni, G, Mehdi, M, Abouassi, A, Abdallah, M, San Andres, M, Eid, J, Aigbivbalu, E, Sundaresan, J, George, B, Ssentongo, A, Ssentongo, P, Oh, JS, Hazelton, J, Maines, J, Gusani, N, Garner, M, Horvath, S, Zheng, F, Ujiki, M, Kinnaman, G, Meagher, A, Sharma, I, Holler, E, McKenzie, K, Chan, J, Fretwell, K, III, Nugent Iii W, Khalil, A, Chen, D, Post, N, Rostkowski, T, Brahmbhatt, D, Huynh, K, Hibbard, ML, Schellenberg, M, Martin, RCG, Bhutiani, N, Giorgakis, E, Laryea, J, Bhavaraju, A, Sexton, K, Kost, M, Kimbrough, M, Burdine, L, Kalkwarf, K, Robertson, R, Gosain, A, Camp, L, Lewit, R, Kronenfeld, JP, Urrechaga, E, Goel, N, Rattan, R, Hart, V, Gilna, G, Cioci, A, Ruiz, G, Rakoczy, K, Pavlis, W, Saberi, R, Morris, R, Karam, BS, Brathwaite, CEM, Liu, H, Petrone, P, Hakmi, H, Sohail, AH, Baltazar, G, Heckburn, R, Nygaard, RM, Colonna, ET, Endorf, FW, Hill, MJ, Maiga, A, Dennis, B, Levin, JH, Lallemand, M, Choron, R, Peck, G, Soliman, F, Rehman, S, Glass, N, Juthani, B, Deisher, D, Ruzgar, NM, Ullrich, SJ, Sion, M, Paranjape, C, Kar, AR, Gillezeau, C, Rapp, J, Taioli, E, Miles, BA, Alpert, N, Podolsky, D, Coleman, NL, Callahan, MP, Ganly, I, Brown, L, Monson, JRT, Dehal, A, Abbas, A, Soliman, A, Kim, B, Jones, C, Dauer, Md, E, Renza-Stingone, E, Hernandez, E, Gokcen, E, Kropf, E, Sufrin, H, Hirsch, H, Ross, H, Engel, J, Sewards, J, Poggio, J, Sanserino, K, Rae, L, Philp, M, Metro, M, McNelis, P, Petrov, R, Pazionis, T, Till, B, Lamm, R, Rios-Diaz, AJ, Palazzo, F, Rosengart, M, Nicholson, K, Carrick, MM, Rodkey, K, Suri, A, Callcut, R, Nicholson, S, Talathoti, N, Klaristenfeld, D, Biffl, W, Marsh, C, Schaffer, K, Berndtson, AE, Averbach, S, Curry, T, Kwan-Feinberg, R, Consorti, E, Gonzalez, R, Grolman, R, Liu, T, Merzlikin, O, Abel, MK, Ozgediz, D, Boeck, M, Kornblith, LZ, Nunez-Garcia, B, Robinson, B, Park, P, Utria, AF, Rice-Townsend, SE, Javid, P, Hauptman, J, Kieran, K, Nehra, D, Walters, A, Cuschieri, J, Davidson, GH, Cosker, R, Eckhouse, S, Choudhry, A, Marx, W, Jamil, T, Seegert, S, Al-Embideen, S, Quintana, M, Jackson, H, Wexner, SD, Kent, I, Martins, PN, Alshehari, M, Al-Naggar, H, Alsayadi, M, Alyazidi, M, Shream, S, Alhaddad, W, Maqus, A, Abu Hamraa, M, Alsayadi, R, Ghannam, R, Al-Maqtari, S, Masdoos, S, Al-Harazi, Y, Bajjah, H, Al-ameri, S, Aldawbali, M, Gwini, GP, Mazingi, D, da Silva, AMR, DAragon, F, D'Agruma, M, D'Andrea, G, Angel, J, Zatecky, J, von Ahnen, T, ter Brugge, FM, Henegouwen, van Berge MI, van der Oest, MJW, van Petersen, AS, van der Meij, W, den Boer, FC, de Lacy, FB, Alga, A, von Fluee, M, ESCP, European Soc Coloproctology, SICCR, Italian Soc Colorectal Surg, ASiT, Assoc Surg Training, ISRC, Irish Surg Res Collaborative, Collaborative, COVIDSurg, European Soc Coloproctology ESCP, Italian Soc Colorectal Surg SICCR, Assoc Surg Training ASiT, Irish Surg Res Collaborative ISRC, COVIDSurg Collaborative, Meister, P. (Beitragende*r), Gallinat, Anja (Beitragende*r), Paul, Andreas (Beitragende*r), Collaborative, COVID Surg, Laboratoire des sciences de l'ingénieur, de l'informatique et de l'imagerie (ICube), École Nationale du Génie de l'Eau et de l'Environnement de Strasbourg (ENGEES)-Université de Strasbourg (UNISTRA)-Institut National des Sciences Appliquées - Strasbourg (INSA Strasbourg), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de Recherche en Informatique et en Automatique (Inria)-Les Hôpitaux Universitaires de Strasbourg (HUS)-Centre National de la Recherche Scientifique (CNRS)-Matériaux et Nanosciences Grand-Est (MNGE), Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Réseau nanophotonique et optique, Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS), Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), COVID Surg Collaborative, Guided Treatment in Optimal Selected Cancer Patients (GUTS), and Robotics and image-guided minimally-invasive surgery (ROBOTICS)
- Subjects
Science & Technology ,AcademicSubjects/MED00910 ,SARS-CoV-2 ,SARS-CoV-2 infection ,fungi ,Medizin ,Bjs/2 ,COVID-19 ,General Medicine ,vaccination ,mortality ,Bacillus Calmette-Guérin ,body regions ,COVID Surg Collaborative ,Research Letter ,BCG Vaccine ,Surgery ,Human medicine ,skin and connective tissue diseases ,AcademicSubjects/MED00010 ,humans ,Life Sciences & Biomedicine ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
There is little evidence around the potentially protective role of previous Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 vaccination. Prior BCG vaccination did not protect SARS-CoV-2 infected patients against postoperative pulmonary complications and 30-day mortality. ispartof: BJS OPEN vol:5 issue:6 ispartof: location:England status: published
- Published
- 2021
- Full Text
- View/download PDF
3. Minimizing maximum tardiness and number of tardy jobs on parallel machines subject to minimum flow-time
- Author
-
Gupta, JND, Ruiz-Torres, AJ, and Webster, S
- Subjects
Business ,Business, general - Abstract
This paper considers the problems of scheduling jobs on parallel identical machines where an optimal schedule is defined as one that gives the smallest maximum tardiness (or the minimum number of tardy jobs) among the set of schedules with optimal total flow-time (the sum of the completion times of all jobs). We show that these problems are unary NP-Hard, develop lower bounds for these two secondary criteria problems, and describe heuristic algorithms for their solution. Results of a computational study show that the proposed heuristic algorithms are quite effective and efficient in solving these hierarchical criteria scheduling problems. Keywords: parallel machine scheduling; hierarchical criteria; maximum tardiness; tardy jobs; flow-time; lower bounds; heuristic algorithms; empirical results
- Published
- 2003
4. Prognostic value of genomic damage in non-small-cell lung cancer
- Author
-
de Juan, C, primary, Iniesta, P, additional, Vega, FJ, additional, Peinado, MA, additional, Fernandez, C, additional, Caldés, T, additional, Jose Massa, M, additional, López, JA, additional, Sánchez, A, additional, Torres, AJ, additional, Balibrea, JL, additional, and Benito, M, additional
- Published
- 1998
- Full Text
- View/download PDF
5. "Taking in the waist": adjusting the size of a stented fontan fenestration.
- Author
-
Torres AJ, Hellenbrand WE, Pass RH, Torres, Alejandro J, Hellenbrand, William E, and Pass, Robert H
- Abstract
Early spontaneous closure of a fenestration following Fontan palliation may complicate the postoperative management of such patients. The creation of a fenestration in the catheterization laboratory with an intravascular stent may improve these patients' hemodynamic status. The aim of this study is to present a new technique to reduce the diameter of stented Fontan fenestrations in those patients in whom the stent diameter is functionally made too large. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
6. Surgical site infection -- a European perspective of incidence and economic burden.
- Author
-
Leaper DJ, Van Goor H, Reilly J, Petrosillo N, Geiss HK, Torres AJ, and Berger A
- Published
- 2004
- Full Text
- View/download PDF
7. Aortopulmonary paraganglioma: An overview after five years
- Author
-
Blanco S, Castañon J, Gil-Aguad M, Torres Aj, Fernando O’Connor, and Ali Alswies
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,business.industry ,General surgery ,Aortic Diseases ,Pulmonary Artery ,Coronary Angiography ,medicine.disease ,Paraganglioma ,Humans ,Medicine ,Surgery ,Vascular Diseases ,Tomography, X-Ray Computed ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Full Text
- View/download PDF
8. SOMATOSTATIN (SS) IN THE TREATMENT OF UPPER GASTROINTESTINAL (GI) BLEEDING - A MULTICENTER CONTROLLED TRIAL
- Author
-
Torres, Aj, Landa, I., Hernandez, F., Jover, Jm, Suarez, A., Arias, J., Cuberes, R., Julio Santoyo, Fernandez, R., Gomez, M., Nisa, E., Rodriguez, Jl, Moreno, E., and Balibrea, Jl
9. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial [corrected] [published erratum appears in LANCET ONCOL 2006 Oct;7(10):797].
- Author
-
Douillard J, Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonzáles-Larriba JL, Grodzki T, Pereira JR, Le Groumellec A, Lorusso V, Clary C, Torres AJ, Dahabreh J, Souquet P, Astudillo J, Fournel P, Artal-Cortes A, Jassem J, Koubkova L, and His P
- Abstract
BACKGROUND: Whether adjuvant chemotherapy improves survival of patients with non-small-cell lung cancer (NSCLC) is not known. We aimed to compare the effect of adjuvant vinorelbine plus cisplatin versus observation on survival in patients with completely resected NSCLC. METHODS: 840 patients with stage IB-IIIA NSCLC from 101 centres in 14 countries were randomly assigned to observation (n=433) or to 30 mg/m(2) vinorelbine plus 100 mg/m(2) cisplatin (n=407). Postoperative radiotherapy was not mandatory and was undertaken according to every centre's policy. The primary endpoint was overall survival. Analysis was by intention to treat. This trial is registered as an International Standard Randomised Controlled Trial, number ISRCTN95053737. FINDINGS: 367 patients in the chemotherapy group and 431 in the control group received their assigned treatment. 301 (36%) patients had stage IB disease, 203 (24%) had stage II disease, and 325 (39%) had stage IIIA disease. Tolerance to chemotherapy mainly included neutropenia in 335 (92%) patients and febrile neutropenia in 34 (9%); seven (2%) toxic deaths were also recorded. Compliance was greater with cisplatin than with vinorelbine (median dose intensity 89% [range 17-108] vs 59% [17-100]). After a median follow-up of 76 months (range 43-116), median survival was 65.7 months (95% CI 47.9-88.5) in the chemotherapy group and 43.7 (35.7-52.3) months in the observation group. Adjusted risk for death was significantly reduced in patients assigned chemotherapy compared with controls (hazard ratio 0.80 [95% CI 0.66-0.96]; p=0.017). Overall survival at 5 years with chemotherapy improved by 8.6%, which was maintained at 7 years (8.4%). INTERPRETATION: Adjuvant vinorelbine plus cisplatin extends survival in patients with completely resected NSCLC, better defining indication of adjuvant chemotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
10. Somatostatin in the management of gastrointestinal fistulas
- Author
-
Torres, AJ, Landa, JL, Moreno, M, Arguello, JM, Silecchia, G, Gomez, M, Hernandez, F, Jover, J, Moreno, E, and Balibrea, JL
- Published
- 1992
- Full Text
- View/download PDF
11. Simultaneous stent implantation for pulmonary artery bifurcation stenosis in infants.
- Author
-
Fujita KT, Barry OM, Torres AJ, Crystal MA, and Turner ME
- Subjects
- Humans, Infant, Retrospective Studies, Male, Female, Treatment Outcome, Follow-Up Studies, Cardiac Catheterization methods, Angiography, Stents, Stenosis, Pulmonary Artery surgery, Stenosis, Pulmonary Artery diagnosis, Pulmonary Artery surgery
- Abstract
Objectives: Pulmonary artery (PA) bifurcation stenosis often requires simultaneous stent placement, which may be technically challenging. Limited data exist regarding this practice in infants. We aim to report the procedural outcomes and safety of bifurcation stent placement in infants., Methods: We performed a single-center retrospective review of infants younger than 12 months who underwent simultaneous stent placement for PA bifurcation stenosis from January 1, 2001 through December 31, 2019., Results: Seventeen infants underwent simultaneous PA bifurcation stent placement. The median age was 6.4 months (1.1-10.1 months), and weight was 5.8 kg (3-10.6 kg). Nine (52.9%) patients had had prior PA intervention. Most stents were placed in central PAs (28, 82.4%), followed by lobar branches (6, 17.6%). All patients received pre-mounted stents. The peak gradient across each branch decreased from 47.4 ± 16 to 18.7 ± 13 mm Hg (P less than .0001). The right ventricle to systemic systolic pressure ratio decreased from systemic (1.0 ± 0.3) to just over half systemic (0.58 ± 0.2) (P = .0001). The minimum vessel diameter increased from 3.6 ± 1.5 to 6.0 ± 1.9 mm (P less than .0001). There were 4 (23.5%) patients with high severity adverse events. There were no procedure-related deaths. The median follow-up period was 83.8 months (5.3 months-19.4 years). All patients had subsequent PA re-intervention at a median time of 8.1 months (2.9 months-8.8 years), and median time to re-operation was 19.1 months (2.9 months-7.5 years)., Conclusions: Simultaneous PA stent placement is an effective strategy for relief of bifurcation stenosis in infants. Future transcatheter interventions are necessary to account for patient growth, but may delay the need for re-operation.
- Published
- 2024
- Full Text
- View/download PDF
12. Immune Response to an Inactivated Vaccine of SARS-CoV-2 (CoronaVac) in an Indigenous Brazilian Population: A Cohort Study.
- Author
-
de Oliveira LA, de Morais IRB, Barbosa MDS, Beutinger Marchioro S, Leite Machado LOC, Ferreira Marques M, da Silva Ferreira T, de Almeida GB, de Oliveira Barbosa D, Leite Torres AJ, and Simionatto S
- Abstract
Introduction: Although the adaptive immune responses to the CoronaVac vaccine are known, their dynamics in indigenous communities remain unclear. In this study, we assessed the humoral and cellular immune responses to CoronaVac (Sinovac Biotech Life Sciences, 2021 NCT05225285, Beijing, China), in immunized Brazilian indigenous individuals., Methods: We conducted a prospective cohort study on indigenous Brazilian people between February 2021 and June 2021. Analyses of immune responses were carried out before (T1) and after a vaccination schedule was completed (T2). Demographic data were collected using a questionnaire., Results: We initially included 328 patients; among them, 120 (36.6%) had no SARS-CoV-2 antibodies. Peripheral blood mononuclear cells (PBMCs) were collected from 106 patients during follow-up visits, of which 91 samples were analyzed by immunophenotyping assay to detect SARS-CoV-2-specific memory T-cell response. Post-vaccination, the levels of memory B-cells and Natural Killer T-lymphocytes increased. Bororó village residents, females, and Terena ethnic group members had higher levels of anti-spike IgG antibodies post-vaccination, whereas alcohol and tobacco users had lower concentrations., Conclusions: To our best knowledge, this was the first comprehensive assessment of antibody and T-cell responses against CoronaVac vaccination in indigenous patients. Our findings showed that antibody response and T-cell immunity against SARS-CoV-2 were present in most patients following the vaccination schedule.
- Published
- 2024
- Full Text
- View/download PDF
13. Preoperative liver regeneration with CD133+ infusion in patients with colorectal liver metastases: proof-of concept trial.
- Author
-
García-Botella A, Martín P, Méndez R, Ortega L, Méndez J, Sastre J, Diez-Valladares L, and Torres AJ
- Subjects
- Humans, Liver Regeneration, Biomarkers, Tumor, Liver Neoplasms surgery, Colorectal Neoplasms surgery
- Published
- 2024
- Full Text
- View/download PDF
14. Side-to-side magnetic duodeno-ileostomy in adults with severe obesity with or without type 2 diabetes: early outcomes with prior or concurrent sleeve gastrectomy.
- Author
-
Gagner M, Almutlaq L, Cadiere GB, Torres AJ, Sanchez-Pernaute A, Buchwald JN, and Abuladze D
- Subjects
- Adult, Humans, Female, Middle Aged, Male, Treatment Outcome, Obesity surgery, Duodenum surgery, Gastrectomy methods, Weight Loss, Retrospective Studies, Magnetic Phenomena, Obesity, Morbid surgery, Obesity, Morbid etiology, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 surgery, Gastric Bypass adverse effects
- Abstract
Background: Conventional metabolic/bariatric surgical anastomoses with sutures/staples may cause severe adverse events (AEs)., Objectives: The study aim was to evaluate the feasibility, safety, and effectiveness of primary and revisional side-to-side duodeno-ileostomy (DI) bipartition using a novel magnetic compression anastomosis device (Magnet Anastomosis System [MS])., Setting: Multicenter: private practices and university hospitals., Methods: In patients with body mass index ([BMI, kg/m
2 ] ≥35.0 to ≤50.0 with/without type 2 diabetes [T2D] glycosylated hemoglobin [HbA1C > 6.5 %]), two linear MS magnets were delivered endoscopically to the duodenum and ileum with laparoscopic assistance and aligned, initiating magnet fusion and gradual DI (MagDI). The MagDI-after-SG group had undergone prior sleeve gastrectomy (SG); the MagDI + SG group underwent concurrent SG. AEs were graded by Clavien-Dindo Classification (CDC)., Results: Between November 22, 2021 and May 30, 2023, 43 patients (88.0% female, mean age 43.7 ± 1.3 years) underwent the study procedures. The MS met feasibility criteria of magnet device placement, creation of patent anastomoses confirmed radiologically, and magnet passage in 100.0% of patients. There were 64 AEs, most were CDC grade I and II, significantly fewer in the MagDI-after-SG group (P < .001). No device-related AEs including anastomotic leakage, bleeding, obstruction, infection, or death. The MagDI-after-SG group experienced 6-month mean weight loss of 8.0 ± 2.5 kg (P < .01), 17.4 ± 5.0% excess weight loss (EWL). The MagDI + SG group had significantly greater weight loss (34.2 ± 1.6 kg, P < .001), 66.2 ± 3.4% EWL. All patients with T2D improved., Conclusions: In early results of a multicenter study, the incisionless, sutureless Magnet System formed patent, complication-free anastomoses in side-to-side DI with prior or concurrent SG., (Copyright © 2024 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
15. Robust method for chromatogram shape analysis to improve early detection of performance drifts and adverse changes in process parameters during purification column operations.
- Author
-
Torres AJ
- Subjects
- Principal Component Analysis, Chromatography, Biological Products
- Abstract
The biopharmaceutical industry is under increased pressure to maximize efficiency, enhance quality compliance, and reduce the cost of drug substance manufacturing. Ways to reduce costs associated with manufacturing of complex biological molecules include maximizing efficiency of chromatography purification steps. For example, process analytical technology (PAT) tools can be employed to improve column resin life, prevent column operating failures, and decrease the time it takes to solve investigations of process deviations. We developed a robust method to probe the shape of the chromatogram for indications of column failure or detrimental changes in the process. The approach herein utilizes raw data obtained from manufacturing followed by a pre-processing routine to align chromatograms and patch together the different chromatogram phases in preparation for multivariate analysis. A principal component analysis (PCA) was performed on the standardized chromatograms to compare different batches, and resulted in the identification specific process change that affected the profile. In addition, changes in the chromatogram peaks were used to create predictive models for impurity clearance. This approach has the potential for early detection of column processing issues, improving timely resolution in large-scale chromatographic operations., (© 2023 Wiley-VCH GmbH.)
- Published
- 2024
- Full Text
- View/download PDF
16. Seroprevalence Of SARS-COV-2 infection in asymptomatic indigenous from the largest Brazilian periurban area.
- Author
-
de Oliveira LA, Dos Santos Barbosa M, Leite Torres AJ, Croda MG, Oliveira da Silva B, Dos Santos PCP, Rossoni R, Machado LOCL, Croda J, Maymone Gonçalves CC, Marques MF, da Silva Ferreira T, Sardi SI, Campos GS, de Almeida GB, Alves Gomes MM, Marchioro SB, and Simionatto S
- Subjects
- Adult, Humans, Antibodies, Viral, Brazil epidemiology, SARS-CoV-2, Seroepidemiologic Studies, Ethnicity, Asymptomatic Infections epidemiology, COVID-19 epidemiology, Indigenous Peoples
- Abstract
This study assessed the seroprevalence of SARS-CoV-2 in 496 asymptomatic individuals from Mato Grosso do Sul, located in Dourados, the largest periurban indigenous area in Brazil, from January 25 to February 4, 2021. The volunteers participated before receiving their first dose of the CoronaVac inactivated vaccine. For screening, blood samples were collected and analyzed using SARS-CoV-2 rapid tests and the enzyme-linked immunosorbent assay (ELISA). We observed varying trends in total anti-SARS-CoV-2 antibodies across different variables. Seropositivity among the participants tested was 63.70% (316/496) using the rapid test and 52.82% (262/496) were positive using the ELISA method. The majority of participants identified with the Guarani-Kaiowá ethnic group, with 66.15% (217/328), and other ethnic groups with 58.84% (193/328). The median age of the subjects was 30.5 years, with 79.57% (261/328) being femaleThis research showed the elevated seroprevalence of SARS-CoV-2 antibodies in asymptomatic Brazilians. The findings indicate a high seropositivity rate among the asymptomatic indigenous population of Midwest Brazil. This underscores the overlooked status of these communities and underscores the need for targeted national initiatives that emphasize the protection of vulnerable ethnic groups in the fight against COVID-19., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2023 de Oliveira et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
17. Study protocol of a randomized controlled trial to assess safety of teleconsultation compared with face-to-face consultation: the ECASeT study.
- Author
-
Rodríguez-Molinero A, Carot-Sans G, Escrig R, Tebé C, Arce J, Pérez-López C, Ballesta S, Verdejo G, Cedeño Á, Riera-Pagespetit M, Vivas-Angeles S, Alarcon JL, Navarro I, Toro S, Mateo L, Torres AJ, Delmás G, Camell H, Chamero A, Gasol M, and Piera-Jiménez J
- Subjects
- Humans, SARS-CoV-2, Pandemics prevention & control, Spain, Treatment Outcome, Randomized Controlled Trials as Topic, Multicenter Studies as Topic, Remote Consultation, COVID-19
- Abstract
Background: The use of remote consultation modalities has exponentially grown in the past few years, particularly since the onset of the COVID-19 pandemic. Although a huge body of the literature has described the use of phone (tele) and video consultations, very few of the studies correspond to randomized controlled trials, and none of them has assessed the safety of these consultation modalities as the primary objective. The primary objective of this trial was to assess the safety of remote consultations (both video and teleconsultation) in the follow-up of patients in the hospital setting., Methods: Multicenter, randomized controlled trial being conducted in four centers of an administrative healthcare area in Catalonia (North-East Spain). Participants will be screened from all individuals, irrespective of age and sex, who require follow-up in outpatient consultations of any of the departments involved in the study. Eligibility criteria have been established based on the local guidelines for screening patients for remote consultation. Participants will be randomly allocated into one of the two study arms: conventional face-to-face consultation (control) and remote consultation, either teleconsultation or video consultation (intervention). Routine follow-up visits will be scheduled at a frequency determined by the physician based on the diagnostic and therapy of the baseline disease (the one triggering enrollment). The primary outcome will be the number of adverse reactions and complications related to the baseline disease. Secondary outcomes will include non-scheduled visits and hospitalizations, as well as usability features of remote consultations. All data will either be recorded in an electronic clinical report form or retrieved from local electronic health records. Based on the complications and adverse reaction rates reported in the literature, we established a target sample size of 1068 participants per arm. Recruitment started in May 2022 and is expected to end in May 2024., Discussion: The scarcity of precedents on the assessment of remote consultation modalities using randomized controlled designs challenges making design decisions, including recruitment, selection criteria, and outcome definition, which are discussed in the manuscript., Trial Registration: NCT05094180. The items of the WHO checklist for trial registration are available in Additional file 1. Registered on 24 November 2021., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
18. The Efficacy and Safety of Laparoscopic Single-Anastomosis Duodeno-ileostomy with Sleeve Gastrectomy (SADI-S) in Mid- and Long-Term Follow-Up: a Systematic Review.
- Author
-
Esparham A, Roohi S, Ahmadyar S, Dalili A, Moghadam HA, Torres AJ, and Khorgami Z
- Subjects
- Humans, Gastrectomy adverse effects, Gastrectomy methods, Duodenum surgery, Anastomosis, Surgical methods, Weight Loss, Retrospective Studies, Obesity, Morbid surgery, Gastroesophageal Reflux surgery, Gastroesophageal Reflux complications, Gastric Bypass methods
- Abstract
This systematic review of 10 studies aimed to investigate the mid- and long-term results of duodeno-ileostomy with sleeve gastrectomy (SADI-S) according to the PRISMA guideline. Related articles, which reported outcomes of laparoscopic SADI-S with follow-up ≥ 3 years, were selected and analyzed. The percentage of excess weight loss (EWL) was 70.9-88.7%, and 80.4% at 6, and 10 years, respectively. The more common late complications were malabsorption (6.3%) and gastroesophageal reflux disease (GERD) (3.6%). The remission rates of hypertension, diabetes, GERD, obstructive sleep apnea, and dyslipidemia were 62.9%, 81.3%, 53.2%, 60.9%, and 69.7%, respectively. In conclusion, SADI-S is a safe and effective surgical technique with durable weight loss and a high rate of comorbidity resolution in mid and long term., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
19. Outcomes and Risk Factors of Interventions for Pediatric Post-operative Pulmonary Vein Stenosis.
- Author
-
Fujita KT, DiLorenzo MP, Krishnan US, Turner ME, Barry OM, Torres AJ, Bacha EA, Kalfa D, and Crystal MA
- Subjects
- Child, Humans, Infant, Newborn, Male, Infant, Constriction, Pathologic, Retrospective Studies, Prospective Studies, Risk Factors, Treatment Outcome, Stenosis, Pulmonary Vein etiology, Stenosis, Pulmonary Vein surgery, Enterocolitis, Necrotizing, Pulmonary Veins surgery, Pulmonary Veins abnormalities, Scimitar Syndrome surgery, Univentricular Heart
- Abstract
Pulmonary vein stenosis (PVS) in children is a challenging condition with poor outcomes. Post-operative stenosis can occur after repair of anomalous pulmonary venous return (APVR) or stenosis within native veins. There is limited data on the outcomes of post-operative PVS. Our objective was to review our experience and assess surgical and transcatheter outcomes. Single-center retrospective study was performed including patients < 18 years who developed restenosis after baseline pulmonary vein surgery that required additional intervention(s) from 1/2005 to 1/2020. Non-invasive imaging, catheterization and surgical data were reviewed. We identified 46 patients with post-operative PVS with 11 (23.9%) patient deaths. Median age at index procedure was 7.2 months (range 1 month-10 years), and median follow-up was 10.8 months (range 1 day-13 years). Index procedure was surgical in 36 (78.3%) and transcatheter in 10 (21.7%). Twenty-three (50%) patients developed vein atresia. Mortality was not associated with number of affected veins, vein atresia, or procedure type. Single ventricle physiology, complex congenital heart disease (CCHD), and genetic disorders were associated with mortality. Survival rate was higher in APVR patients (p = 0.03). Patients with three or more interventions had a higher survival rate compared to patients with 1-2 interventions (p = 0.02). Male gender, necrotizing enterocolitis, and diffuse hypoplasia were associated with vein atresia. In post-operative PVS, mortality is associated with CCHD, single ventricle physiology, and genetic disorders. Vein atresia is associated with male gender, necrotizing enterocolitis, and diffuse hypoplasia. Multiple repeated interventions may offer a patient survival benefit; however, larger prospective studies are necessary to elucidate this relationship further., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
20. Comparative analysis of 5-year efficacy and outcomes of single anastomosis procedures as revisional surgery for weight regain following sleeve gastrectomy.
- Author
-
Salama AF, Baazaoui J, Shahid F, Singh R, Torres AJ, and Bashah MM
- Subjects
- Humans, Retrospective Studies, Gastrectomy adverse effects, Gastrectomy methods, Reoperation methods, Weight Loss, Weight Gain, Obesity, Morbid surgery, Obesity, Morbid complications, Gastric Bypass adverse effects, Gastric Bypass methods
- Abstract
Background: It is imperative to assess the results of revisional procedures following Sleeve Gastrectomy (SG), given the substantially growing population of patients who experience weight regain within a few years after undergoing this procedure., Objective: Examine the comparative effectiveness of the Single Anastomosis Duodeno-Ileal Bypass (SADI-S) and the One Anastomosis Gastric Bypass (OAGB-MGB) as revisional procedures, with respect to their impact on weight loss, resolution of comorbidities, incidence of complications, and rates of reoperation in patients who had weight regain after SG with up to or more than 5 years of follow-up., Setting: Hamad General Hospital, Academic tertiary referral center, Qatar., Methods: This study retrospectively analyzed a database of patients who underwent the Single Anastomosis Duodeno-Ileal Switch (SADI-S) or the One Anastomosis Gastric Bypass - Mini Gastric Bypass- (OAGB-MGB) as revisional procedures for weight recidivism after a primary Laparoscopic Sleeve Gastrectomy (LSG). The follow-up period was at least 5 years, during which the impact of both procedures on weight loss, comorbidities, nutritional deficiencies, complications, and outcomes were compared., Results: The study comprised 91 patients, with 42 and 49 in the SADI-S and OAGB-MGB groups, respectively. Significant weight loss (measured by total weight loss percentage, TWL%) was observed at the 5-year follow-up for the SADI-S group compared to the OAGB-MGB group (30.0 ± 18.4 vs. 19.4 ± 16.3, p = 0.008). Remission of comorbidities, specifically diabetes mellitus and hypertension, was more prevalent in the SADI-S group. Notably, the OAGB-MGB group had a higher incidence of complications (28.6% vs. 21.42%) and reoperations (5 patients vs. 1 in the SADI-S group). No mortality events were reported in either group., Conclusion: While both the OAGB-MGB and SADI-S have demonstrated efficacy as revisional procedures for weight regain following SG, the SADI-S exhibits superior outcomes compared to the OAGB-MGB with regard to weight loss, resolution of comorbidities, complication rates, and reoperation rates., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
21. Side-to-side magnet anastomosis system duodeno-ileostomy with sleeve gastrectomy: early multi-center results.
- Author
-
Gagner M, Cadiere GB, Sanchez-Pernaute A, Abuladze D, Krinke T, Buchwald JN, Van Sante N, Van Gossum M, Dziakova J, Koiava L, Odovic M, Poras M, Almutlaq L, and Torres AJ
- Subjects
- Adult, Humans, Female, Male, Magnets, Duodenum surgery, Anastomosis, Surgical methods, Obesity surgery, Gastrectomy methods, Weight Loss, Retrospective Studies, Diabetes Mellitus, Type 2 surgery, Obesity, Morbid surgery, Gastric Bypass methods
- Abstract
Introduction: Gastrointestinal anastomoses with classical sutures and/or metal staples have resulted in significant bleeding and leak rates. This multi-site study evaluated the feasibility, safety, and preliminary effectiveness of a novel linear magnetic compression anastomosis device, the Magnet System (MS), to form a side-to-side duodeno-ileostomy (DI) diversion for weight loss and type 2 diabetes (T2D) resolution., Methods: In patients with class II and III obesity (body mass index [BMI, kg/m
2 ] ≥ 35.0- ≤ 50.0 with/without T2D [HbA1C > 6.5%]), two linear MS magnets were delivered endoscopically to the duodenum and ileum with laparoscopic assistance and aligned, initiating DI; sleeve gastrectomy (SG) was added. There were no bowel incisions or retained sutures/staples. Fused magnets were expelled naturally. Adverse events (AEs) were graded by Clavien-Dindo Classification (CDC)., Results: Between November 22, 2021 and July 18, 2022, 24 patients (83.3% female, mean ± SEM weight 121.9 ± 3.3 kg, BMI 44.4 ± 0.8) in three centers underwent magnetic DI. Magnets were expelled at a median 48.5 days. Respective mean BMI, total weight loss, and excess weight loss at 6 months (n = 24): 32.0 ± 0.8, 28.1 ± 1.0%, and 66.2 ± 3.4%; at 12 months (n = 5), 29.3 ± 1.5, 34.0 ± 1.4%, and 80.2 ± 6.6%. Group mean respective mean HbA1C and glucose levels dropped to 1.1 ± 0.4% and 24.8 ± 6.6 mg/dL (6 months); 2.0 ± 1.1% and 53.8 ± 6.3 mg/dL (12 months). There were 0 device-related AEs, 3 procedure-related serious AEs. No anastomotic bleeding, leakage, stricture, or mortality., Conclusion: In a multi-center study, side-to-side Magnet System duodeno-ileostomy with SG in adults with class III obesity appeared feasible, safe, and effective for weight loss and T2D resolution in the short term., (© 2023. The Author(s).)- Published
- 2023
- Full Text
- View/download PDF
22. Combined Effect of Genetic Variants on Long-Term Weight Response after Bariatric Surgery.
- Author
-
Torrego-Ellacuría M, Barabash A, Matía-Martín P, Sánchez-Pernaute A, Torres AJ, Calle-Pascual AL, and Rubio-Herrera MA
- Abstract
The pathophysiology of body weight control involves complex interactions between hormonal, environmental, behavioral and genetic factors. The purpose of this study was to analyze the association between single nucleotide polymorphisms (SNPs) of 13 genes encoding gastrointestinal peptides, their receptors or the proteins involved in their expression, with long-term weight response in a cohort of 375 patients undergoing bariatric surgery (BS). To evaluate weight response, we combined several variables to define specific response phenotypes six years after surgery. The study protocol was registered in ISRCTN (ID80961259). The analysis of the selected SNPs was performed via allelic discrimination using Taqman
® probes (Applied Biosystems, Foster City, CA, USA). The genotype association study was performed using the SNPstat program, with comparisons adjusted for sex, age, initial body mass index, type 2 diabetes, hypertension diagnosis and the type of surgery. We identified eight genetic variants associated with the weight response to BS, independently of the presurgery patient profile and the type of surgical technique, from which we calculated the unweighted risk score (RS) for each phenotype. The highest scoring category in each RS was significantly associated with lower weight loss ( p = 0.0001) and greater weight regain ( p = 0.0012) at the end of the follow-up.- Published
- 2023
- Full Text
- View/download PDF
23. Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer-Relationship to the Body Mass Index.
- Author
-
Tesolato SE, González-Gamo D, Barabash A, Claver P, de la Serna SC, Domínguez-Serrano I, Dziakova J, de Juan C, Torres AJ, and Iniesta P
- Abstract
This work aims to investigate the expression levels of four preselected miRNAs previously linked to cancer and/or obesity, with the purpose of finding potential biomarkers in the clinical management of CRC developed by patients showing different BMI values. We analyzed samples from a total of 65 subjects: 43 affected by CRC and 22 without cancer. Serum and both subcutaneous and omental adipose tissues (SAT and OAT) were investigated, as well as tumor and non-tumor colorectal tissues in the case of the CRC patients. The relative expression (2
-∆∆Ct ) levels of 4 miRNAs (hsa-miR-181a-5p, hsa-miR-143-3p, has-miR-132-3p and hsa-miR-23a-3p) were measured by RT-qPCR. Serum, SAT and OAT expression levels of these miRNAs showed significant differences between subjects with and without CRC, especially in the group of overweight/obese subjects. In CRC, serum levels of hsa-miR-143-3p clearly correlated with their levels in both SAT and OAT, independently of the BMI group. Moreover, hsa-miR-181a-5p could be considered as a biomarker in CRC patients with BMI ≥ 25 Kg/m2 and emerges as a tumor location marker. We conclude that both adiposity and CRC induce changes in the expression of the miRNAs investigated, and hsa-miR-143-3p and hsa-miR-181a-5p expression analysis could be useful in the clinical management of CRC.- Published
- 2023
- Full Text
- View/download PDF
24. Outcomes after neonatal cardiac surgery: The impact of a dedicated neonatal cardiac program.
- Author
-
Goldshtrom N, Vasquez AM, Chaves DV, Bateman DA, Kalfa D, Levasseur S, Torres AJ, Bacha E, and Krishnamurthy G
- Subjects
- Infant, Female, Infant, Newborn, Humans, Infant, Premature, Gestational Age, Infant, Premature, Diseases, Cardiac Surgical Procedures adverse effects, Heart Defects, Congenital surgery
- Abstract
Objectives: Prematurity is a risk factor for in-hospital mortality after cardiac surgery. The structure of intensive care unit models designed to deliver optimal care to neonates including those born preterm with critical congenital heart disease is unknown. The objective of this study was to evaluate in-hospital outcomes after cardiac surgery across gestational ages in an institution with a dedicated neonatal cardiac program., Methods: This study is a single-center, retrospective review of infants who underwent cardiac surgical interventions from our dedicated neonatal cardiac intensive care program between 2006 and 2017. We evaluated in-hospital mortality and morbidity rates across all gestational ages., Results: A total of 1238 subjects met inclusion criteria over a 11-year period. Overall in-hospital mortality after cardiac surgery was 6.1%. The mortality rate in very preterm infants (n = 68; <34 weeks' gestation at birth) was 17.6% (odds ratio, 3.52 [1.4-8.53]), versus 4.3% in full-term (n = 563; 39-40 weeks) referent/control infants. Very preterm infants with isolated congenital heart disease (without evidence of other affected organ systems) experienced a mortality rate of 10.5% after cardiac surgery. Neither the late preterm (34-36
6/7 weeks) nor the early term (37-386/7 ) groups had significantly increased odds of mortality compared with full-term infants. Seventy-eight percent of very preterm infants incurred a preoperative or postoperative complication (odds ratio, 4.78 [2.61-8.97]) compared with 35% of full-term infants., Conclusions: In this study of a single center with a dedicated neonatal cardiac program, we report some of the lowest mortality and morbidity rates after cardiac surgery in preterm infants in the recent era. The potential survival advantage of this model is most striking for very preterm infants born with isolated congenital heart disease., (Copyright © 2022 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
25. Congenital Pulmonic Valve Dysfunction Treated With SAPIEN 3 Transcatheter Heart Valve (from the COMPASSION S3 Trial).
- Author
-
Lim DS, Kim D, Aboulhosn J, Levi D, Fleming G, Hainstock M, Sommer R, Torres AJ, Zhao Y, Shirali G, and Babaliaros V
- Subjects
- Humans, Adult, Prospective Studies, Empathy, Cardiac Catheterization adverse effects, Treatment Outcome, Prosthesis Design, Time Factors, Heart Valve Prosthesis Implantation adverse effects, Heart Valve Prosthesis, Pulmonary Valve surgery, Pulmonary Valve Insufficiency surgery
- Abstract
Significant pulmonary regurgitation (PR) and pulmonary stenosis are common after surgical repair of some congenital heart defects. This prospective, single-arm, multicenter trial enrolled patients who underwent transcatheter heart valve (THV) implantation with a SAPIEN 3 valve to treat dysfunctional right ventricular outflow tract (RVOT) conduits or pulmonic surgical valves (≥ moderate PR and/or mean RVOT gradient ≥35 mm Hg). The primary end point was a nonhierarchical composite of THV dysfunction at 1 year comprising RVOT reintervention, ≥ moderate total PR, and mean RVOT gradient >40 mm Hg. A performance goal of <25% of upper confidence interval (CI) was prespecified for the primary end point, using a 95% exact binomial CI. Patients (n = 58) were enrolled between July 5, 2016 and July 17, 2018, with mean age of 32 years. Prestenting was performed in 53.4%. At discharge, the device success was 98.1% (single valve without explant, < moderate PR, gradient <35 mm Hg). At 30 days, there were no major adjudicated adverse clinical events. At 1 year, the primary end point composite was 4.3% (95% CI 0.5 to 14.5). The composite components were 0% (0 of 56) RVOT reintervention, 2.1% (1 of 47) ≥ moderate PR, and 2.1% (1 of 48) mean RVOT gradient >40 mm Hg. No mortality, endocarditis, thrombosis, or stent fracture were reported at 1 year. In conclusion, the SAPIEN 3 THV was safe and effective in patients with dysfunctional RVOT conduits or previously implanted valves in the pulmonic position to 1 year. Clinical trial registration: NCT02744677; https://clinicaltrials.gov/ct2/show/NCT02744677., (Copyright © 2022. Published by Elsevier Inc.)
- Published
- 2023
- Full Text
- View/download PDF
26. Avoiding Complications During Revisional Bariatric Surgery with Indocyanine Green Fluorescence Imaging.
- Author
-
Sánchez-Pernaute A, López-Antoñanzas L, Torres AJ, Dziakova J, Rubio MA, and Pérez-Aguirre E
- Subjects
- Humans, Indocyanine Green, Optical Imaging, Retrospective Studies, Reoperation methods, Obesity, Morbid surgery, Gastric Bypass methods, Bariatrics, Bariatric Surgery methods, Laparoscopy methods
- Published
- 2023
- Full Text
- View/download PDF
27. Serratus Posterior Superior Intercostal Plane Block: A Technical Report on the Description of a Novel Periparavertebral Block for Thoracic Pain.
- Author
-
Tulgar S, Ciftci B, Ahiskalioglu A, Bilal B, Sakul BU, Korkmaz AO, Bozkurt NN, De Cassai A, Torres AJ, Elsharkawy H, and Alici HA
- Abstract
Background and objective We report a novel block technique aimed to provide thoracic analgesia: the serratus posterior superior intercostal plane (SPSIP) block. Design A cadaveric evaluation along with a retrospective case series evaluating the potential analgesic effect of the SPSIP block. This study included one unembalmed cadaver and five patients. Interventions Bilateral ultrasound-guided SPSIP block was used on cadavers with 30 mL of methylene blue 0.5% on each side; single-injection SPSIP blocks were used in patients. To measure results, dye spread was used in the cadaver, and dermatomal/pain score evaluation was used in patients. Main results Anatomical investigation in one unembalmed cadaver shows that its mechanism of action covers the rhomboid major muscle, erector spinae muscle, the deep fascia of the subscapularis/serratus anterior muscles, and intercostal nerves. In our patients, SPSIP resulted in an almost complete sensory block in the back of the neck, shoulder, and hemithorax. Conclusion Our cadaveric study shows extensive dye spread from C7 to T7. Patients who were administrated SPSIP block reported consistent dermatomal blockade from C3 to T10 levels of the hemitorax. The SPSIP block seems to be a safe, simple, and effective technique for thoracic analgesia., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2023, Tulgar et al.)
- Published
- 2023
- Full Text
- View/download PDF
28. Attitudes Toward Lesbians, Gay Men, and Their Rights in a Sample of Ecuadorian Cisgender Men and Women.
- Author
-
Hermosa-Bosano C, Hidalgo-Andrade P, Olaya-Torres AJ, Duque-Romero C, Costa PA, and Salinas-Quiroz F
- Subjects
- Female, Humans, Male, Homosexuality, Male, Attitude, Prejudice, Homosexuality, Female, Sexual and Gender Minorities
- Abstract
Since 1997, Ecuador has undergone a series of changes to ensure family rights to sexual minorities. However, there is still limited research regarding attitudes toward them. This study focused on the attitudes toward lesbians (L), gay men (G), and their rights. A sample of 318 cisgender Ecuadorians who responded to an online survey was recruited. Analyses indicated that men, heterosexuals, who practice their religion, attend more frequently to religious services, and identify as conservative showed higher levels of prejudice against LG as well as less support toward their rights. Further, participants who did not have LG acquaintances, friends, family members, and those who did not know any LG parented family showed less support toward these populations. Multiple regression analyses indicated that believing that a person's sexual orientation is learned significantly predicted the attitudes measured in our study. Implications of these findings to help reduce prejudice against LG individuals are discussed.
- Published
- 2023
- Full Text
- View/download PDF
29. Telomere Length and Telomerase Activity in Subcutaneous and Visceral Adipose Tissues from Obese and Non-Obese Patients with and without Colorectal Cancer.
- Author
-
García-Martínez S, González-Gamo D, Tesolato SE, Barabash A, de la Serna SC, Domínguez-Serrano I, Dziakova J, Rivera D, Torres AJ, and Iniesta P
- Abstract
To investigate the molecular mechanisms that link obesity and colorectal cancer (CRC), we analyzed parameters related to telomere function in subcutaneous and visceral adipose tissues (SAT and VAT), including subjects with and without CRC, who were classified according to their body mass index (BMI). Adipose tissues were obtained from 147 patients who had undergone surgery. A total of 66 cases corresponded to CRC patients, and 81 subjects were not affected by cancer. Relative telomere length was established by qPCR, and telomerase activity was determined by a method based on the telomeric repeat amplification protocol. Our results indicated longer telomeres in patients affected by CRC, both in SAT and VAT, when compared to the group of subjects without CRC. Tumor local invasion was associated with telomere length (TL) in SAT. Considering the BMI values, significant differences were found in the TL of both adipose tissues between subjects affected by CRC and those without cancer. Overweight subjects showed the greatest differences, with longer telomeres in the group of CRC patients, and a higher number of cases with telomerase reactivation in the VAT of subjects without cancer. In conclusion, parameters related to telomere function in adipose tissue could be considered as potential biomarkers in the evaluation of CRC and obesity.
- Published
- 2022
- Full Text
- View/download PDF
30. Information concealment in palliative patients: Development and pilot study of a new scale for caregivers.
- Author
-
de la Piedra-Torres AJ, López-Martínez AE, and Ramírez-Maestre C
- Subjects
- Male, Humans, Female, Psychometrics, Reproducibility of Results, Pilot Projects, Surveys and Questionnaires, Caregivers, Palliative Care
- Abstract
Previous studies on palliative care have assessed the phenomenon of Information Concealment (IC), confirmed its relevance and emphasised the need to have a scale for its assessment. The aim of this study was to design and validate such an instrument. The sample comprised 150 palliative caregivers (23 men and 127 women). The dimensionality of the items of the Information Concealment Scale for Caregivers (ECOI) was assessed using Exploratory Factor Analysis and an optimal implementation of parallel analysis. Reliability and criterion validity were analysed using sample data. The ECOI comprises three factors: Concealment or dissimulation about the disease, misrepresentation of the real situation and control of the information. The scale has excellent reliability and shows criterion validity. Therefore, the ECOI is a reliable and valid instrument to objectively measure IC among Spanish caregivers in palliative care settings., (© 2022 The Authors. Health and Social Care in the Community published by John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
31. Full-scale Randomized Trial Comparing Acceptance and Commitment Therapy Telephone-Delivered Coaching With Standard Telephone-Delivered Coaching Among Medicare/Uninsured Quitline Callers.
- Author
-
Bricker JB, Sullivan BM, Mull KE, Torres AJ, and Carpenter KM
- Subjects
- Adult, Aged, Female, Humans, Male, Medically Uninsured, Medicare, Middle Aged, Telephone, Tobacco Use Cessation Devices, United States, Acceptance and Commitment Therapy, Mentoring, Smoking Cessation
- Abstract
Introduction: The aim of this study was to compare Acceptance and Commitment Therapy (ACT) telephone-delivered coaching with standard quitline (QL) telephone-delivered coaching., Methods: Medicare/uninsured adults (analyzable sample N = 1170) who smoked at least 10 cigarettes per day were recruited from Optum, a major US provider of QL services, in a two-arm stratified double-blind randomized trial with main outcome of self-reported missing = smoking 30-day point prevalence abstinence (PPA) at the 12-month follow-up. Participants were mean (SD) age 47.4 (12.7), 61% female, and 72% white race. Five sessions of telephone-delivered ACT or QL interventions were offered. Both arms included combined nicotine patch (4 weeks) and gum or lozenge (2 weeks)., Results: The 12-month follow-up data retention rate was 67.8%. ACT participants reported their treatment was more useful for quitting smoking (92.0% for ACT vs. 82.3% for QL; odds ratio [OR] = 2.48; 95% confidence interval [CI]: 1.53 to 4.00). Both arms had similar 12-month cessation outcomes (missing = smoking 30-day PPA: 24.6% for ACT vs. 28.8% for QL; OR =.81; 95% CI: 0.62 to 1.05) and the ACT arm trended toward greater reductions in number cigarettes smoked per day (-5.6 for ACT vs. -1.7 QL, among smokers; p = .075)., Conclusions: ACT telephone-delivered coaching was more satisfying, engaging, and was as effective as standard QL telephone-delivered coaching. ACT may help those who fail to quit after standard coaching or who choose not to use nicotine replacement therapy., Implications: In a sample of Medicare and uninsured QL callers, a large randomized trial with long-term follow-up showed that ACT) telephone-delivered coaching was more satisfying, engaging, and was as effective as standard QL telephone-delivered coaching-which has followed the same behavior change approach since the 1990s. This newer model of coaching might be a welcome addition to QL services., (© The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
32. In COVID-19 Health Messaging, Loss Framing Increases Anxiety with Little-to-No Concomitant Benefits: Experimental Evidence from 84 Countries.
- Author
-
Dorison CA, Lerner JS, Heller BH, Rothman AJ, Kawachi II, Wang K, Rees VW, Gill BP, Gibbs N, Ebersole CR, Vally Z, Tajchman Z, Zsido AN, Zrimsek M, Chen Z, Ziano I, Gialitaki Z, Ceary CD, Lin Y, Kunisato Y, Yamada Y, Xiao Q, Jiang X, Du X, Yao E, Wilson JP, Cyrus-Lai W, Jimenez-Leal W, Law W, Collins WM, Richard KL, Vranka M, Ankushev V, Schei V, Križanić V, Kadreva VH, Adoric VC, Tran US, Yeung SK, Hassan W, Houston R, Lima TJS, Ostermann T, Frizzo T, Sverdrup TE, House T, Gill T, Fedotov M, Paltrow T, Jernsäther T, Koptjevskaja-Tamm M, Hostler TJ, Ishii T, Szaszi B, Adamus S, Suter L, Habib S, Studzinska A, Stojanovska D, Janssen SMJ, Stieger S, Schulenberg SE, Tatachari S, Azouaghe S, Sorokowski P, Sorokowska A, Song X, Lewis SC, Sinkolova S, Grigoryev D, Drexler SM, Daches S, Geniole SN, Vračar S, Massoni S, Zorjan S, Sarıoğuz E, Izquierdo SM, Alves SG, Pöntinen S, Solas SÁ, Ordoñez-Riaño S, Očovaj SB, Onie S, Lins S, Çoksan S, Sacakli A, Ruiz-Fernández S, Geiger SJ, FatahModares S, Walczak RB, Betlehem R, Vilar R, Cárcamo R, Ross RM, McCarthy R, Ballantyne T, Westgate EC, Afhami R, Ren D, Monteiro RP, Reips UD, Reggev N, Calin-Jageman RJ, Pourafshari R, Oliveira R, Nedelcheva-Datsova M, Rahal RM, Ribeiro RR, Radtke T, Searston R, Habte R, Zdybek P, Chen SC, Maturan PLG, Perillo JT, Isager PM, Kačmár P, Macapagal PM, Szwed P, Hanel PHP, Forbes PAG, Arriaga P, Paris B, Papachristopoulos K, Correa PS, Kácha O, Bernardo M, Campos O, Bravo ON, Galindo-Caballero OJ, Ogbonnaya CE, Bialobrzeska O, Kiselnikova N, Simonovic N, Cohen N, Nock NL, Johannes N, Albayrak-Aydemir N, Say N, Torunsky N, Van Doren N, Sunami N, Rachev NR, Majeed NM, Schmidt ND, Nadif K, Corral-Frías NS, Ouherrou N, Pantazi M, Lucas MY, Vasilev MR, Ortiz MV, Butt MM, Kabir M, Muda R, Tejada Rivera MDCM, Sirota M, Seehuus M, Parzuchowski M, Toro M, Hricova M, Maldonado MA, Marszalek M, Karekla M, Mioni G, Bosma MJ, Westerlund M, Vdovic M, Bialek M, Silan MA, Anne M, Misiak M, Grinberg M, Capizzi M, Espinoza Barría MF, Kurfali MA, Mensink MC, Harutyunyan M, Khosla M, Korbmacher M, Adamkovič M, Ribeiro MFF, Terskova M, Hruška M, Martončik M, Voracek M, Čadek M, Frías-Armenta M, Kowal M, Topor M, Roczniewska M, Oosterlinck M, Kohlová MB, Paruzel-Czachura M, Romanova M, Papadatou-Pastou M, Lund ML, Antoniadi M, Jones MV, Ortiz MS, Manavalan M, Muminov A, Kossowska M, Friedemann M, Wielgus M, Varella MAC, Colloff MF, Bradford M, Vaughn LA, Eudave L, Vieira L, Pineda LMS, Pérez LC, Lazarevic LB, Jaremka LM, Kushnir E, Anton-Boicuk L, de Holanda Coelho GL, Ahlgren L, Levitan CA, Micheli L, Volz L, Stojanovska M, Boucher L, Samojlenko L, Delgado LGJ, Kaliska L, Warmelink L, Rojas-Berscia LM, Yu K, Wachowicz J, Desai K, Barzykowski K, Kozma L, Evans K, Kirgizova K, Agesin BE, Koehn MA, Wolfe K, Korobova T, Klevjer K, van Schie K, Vezirian K, Damnjanović K, Thommesen KK, Schmidt K, Filip K, Grzech K, Hoyer K, Moon K, Rana K, Janjić K, Suchow JW, Kielińska J, Cruz Vásquez JE, Beitner J, Vargas-Nieto JC, Roxas JCT, Taber J, Urriago-Rayo J, Pavlacic JM, Bavolar J, Soto JA, Olofsson JK, Vilsmeier JK, Messerschmidt J, Czamanski-Cohen J, Boudesseul J, Lee JM, Kamburidis J, Zickfeld J, Miranda JF, Verharen JPH, Hristova E, Beshears JE, Đorđević JM, Bosch J, Valentova JV, Antfolk J, Berkessel JB, Schrötter J, Urban J, Röer JP, Norton JO, Silva JR, Pickering JS, Vintr J, Uttley J, Kunst JR, Ndukaihe ILG, Iyer A, Vilares I, Ivanov A, Ropovik I, Sula I, Sarieva I, Metin-Orta I, Prusova I, Pinto I, Bozdoc AI, Almeida IAT, Pit IL, Dalgar I, Zakharov I, Arinze AI, Ihaya K, Stephen ID, Gjoneska B, Brohmer H, Flowe H, Godbersen H, Kocalar HE, Hedgebeth MV, Chuan-Peng H, Sharifian M, Manley H, Akkas H, Hajdu N, Azab H, Kaminski G, Nilsonne G, Anjum G, Travaglino GA, Feldman G, Pfuhl G, Czarnek G, Marcu GM, Hofer G, Banik G, Adetula GA, Bijlstra G, Verbruggen F, Kung FYH, Foroni F, Singer G, Muchembled F, Azevedo F, Mosannenzadeh F, Marinov E, Štrukelj E, Etebari Z, Baskin E, Garcia EOL, Musser E, van Steenkiste IMM, Ahn ER, Pronizius E, Jackson EA, Manunta E, Agadullina E, Šakan D, Dursun P, Dujols O, Dubrov D, Willis M, Tümer M, Beaudry JL, Popović D, Dunleavy D, Djamai I, Krupić D, Vega D, Du H, Mola D, Davis WE, Holford DL, Lewis DMG, Vaidis DC, Ozery DH, Ricaurte DZ, Storage D, Sousa D, Alvarez DS, Rosa AD, Krupić D, Marko D, Moreau D, Reeck C, Correia RC, Whitt CM, Lamm C, Solorzano CS, von Bastian CC, Sutherland CA, Overkott C, Aberson CL, Wang C, Karashiali C, Noone C, Chiu F, Picciocchi C, Karaarslan C, Cellini N, Esteban-Serna C, Reyna C, Batres C, Li R, Grano C, Carpentier J, Tamnes CK, Fu CHY, Ishkhanyan B, Bylinina L, Jaeger B, Bundt C, Allred TB, Bokkour A, Bogatyreva N, Chopik WJ, Antazo B, Behzadnia B, Becker M, Cocco B, Chou WL, Hubena B, Žuro B, Aczel B, Baklanova E, Bai H, Balci BB, Babinčák P, Dixson BJW, Mokady A, Kappes HB, Atari M, Szala A, Szabelska A, Aruta JJB, Domurat A, Arinze NC, Modena A, Adiguzel A, Monajem A, Arabi KAE, Özdoğru AA, Olaya Torres AJ, Theodoropoulou A, Jurković AP, Kassianos AP, Findor A, Hartanto A, Thibault Landry A, Ferreira A, Santos AC, De la Rosa-Gomez A, Gourdon-Kanhukamwe A, Todsen AL, Karababa A, Janak A, Bran A, Tullett AM, Kuzminska AO, Krafnick AJ, Urooj A, Khaoudi A, Ahmed A, Groyecka-Bernard A, Askelund AD, Adetula A, Belaus A, Charyate AC, Wichman AL, Stoyanova A, Greenburgh A, Thomas AG, Arvanitis A, Forscher PS, Mallik PR, Primbs MA, Miller JK, Moshontz H, Urry HL, IJzerman H, Basnight-Brown DM, Chartier CR, Buchanan EM, and Coles NA
- Abstract
The COVID-19 pandemic (and its aftermath) highlights a critical need to communicate health information effectively to the global public. Given that subtle differences in information framing can have meaningful effects on behavior, behavioral science research highlights a pressing question: Is it more effective to frame COVID-19 health messages in terms of potential losses (e.g., "If you do not practice these steps, you can endanger yourself and others") or potential gains (e.g., "If you practice these steps, you can protect yourself and others")? Collecting data in 48 languages from 15,929 participants in 84 countries, we experimentally tested the effects of message framing on COVID-19-related judgments, intentions, and feelings. Loss- (vs. gain-) framed messages increased self-reported anxiety among participants cross-nationally with little-to-no impact on policy attitudes, behavioral intentions, or information seeking relevant to pandemic risks. These results were consistent across 84 countries, three variations of the message framing wording, and 560 data processing and analytic choices. Thus, results provide an empirical answer to a global communication question and highlight the emotional toll of loss-framed messages. Critically, this work demonstrates the importance of considering unintended affective consequences when evaluating nudge-style interventions., Competing Interests: Conflict of InterestThe authors declare no conflict of interest., (© The Society for Affective Science 2022.)
- Published
- 2022
- Full Text
- View/download PDF
33. How to Better Value EMS Clinicians as Key Care Team Members.
- Author
-
Torres AJ and McCoy RG
- Subjects
- Allied Health Personnel, Humans, Patient Care Team, Emergency Medical Services, Emergency Medical Technicians
- Abstract
Emergency medical services (EMS) clinicians, including emergency medical technicians and paramedics, are skilled professionals whose expertise is leveraged routinely to meet a wide range of patient needs. Collaborative interdisciplinary care requires mutual understanding, trust, and respect. Yet, among EMS clinicians and in- and out-of-hospital clinicians, these values are too often not expressed in working relationships. This article offers guidance on how to nourish successful partnerships with EMS clinicians and motivate good care., (Copyright 2022 American Medical Association. All Rights Reserved.)
- Published
- 2022
- Full Text
- View/download PDF
34. Influence of CLOCK Gene Variants on Weight Response after Bariatric Surgery.
- Author
-
Torrego-Ellacuría M, Barabash A, Matía-Martín P, Sánchez-Pernaute A, Torres AJ, Calle-Pascual AL, and Rubio-Herrera MA
- Subjects
- Body Mass Index, Case-Control Studies, Humans, Polymorphism, Single Nucleotide, Weight Gain, Weight Loss, Bariatric Surgery, CLOCK Proteins genetics, CLOCK Proteins metabolism, Diabetes Mellitus, Type 2 genetics, Diabetes Mellitus, Type 2 surgery, Obesity, Morbid genetics, Obesity, Morbid surgery
- Abstract
The Circadian Locomotor Output Cycles Kaput (CLOCK) gene has been linked to metabolic dysfunction and obesity. The purpose of this study was to analyze the association between single nucleotide polymorphisms (SNPs) of CLOCK gene with obesity and with long-term weight response after different bariatric surgery (BS) techniques. The cohort includes 375 patients with morbid obesity (MO) and 230 controls. In the association study of SNPs with weight response we combined several variables as phenotype at 6 years after surgery. The study protocol was registered in ISRCTN (ID80961259). The analysis of the selected SNPs was performed by allelic discrimination using Taqman
® probes. The genotype association study was performed using the SNPStats program, with comparisons adjusted for sex, age, initial Body Mass Index, type 2 diabetes and hypertension diagnosis, and type of surgery. In the case-control study two of three SNPs were significantly associated with MO. The variant rs1801260 had a protective effect for MO whereas the TT genotype of rs3749474 variant had the strongest association with MO (OR = 2.25 (1.39-3.66); p = 0.0006). In the linear regression analysis both variants showed significant association with long-term weight loss and weight regain after BS, independently of the pre-surgery patient profile.- Published
- 2022
- Full Text
- View/download PDF
35. Spatiotemporal Surveillance of SARS-CoV-2 in the Sewage of Three Major Urban Areas in Peru: Generating Valuable Data Where Clinical Testing Is Extremely Limited.
- Author
-
Pardo-Figueroa B, Mindreau-Ganoza E, Reyes-Calderon A, Yufra SP, Solorzano-Ortiz IM, Donayre-Torres AJ, Antonini C, Renom JM, Quispe AM, Mota CR, Chernicharo CAL, Carbajal MA, and Santa-María MC
- Abstract
Peru has been severely affected by the COVID-19 pandemic. By January 2022, Peru had surpassed 200 000 COVID-19 deaths, constituting the highest death rate per capita worldwide. Peru has had several limitations during the pandemic: insufficient testing access, limited contact tracing, a strained medical infrastructure, and many economic hurdles. These limitations hindered the gathering of accurate information about infected individuals with spatial resolution in real time, a critical aspect of effectively controlling the pandemic. Wastewater monitoring for SARS-CoV-2 RNA offered a promising alternative for providing needed population-wide information to complement health care indicators. In this study, we demonstrate the feasibility and value of implementing a decentralized SARS-CoV-2 RNA wastewater monitoring system to assess the spatiotemporal distribution of COVID-19 in three major cities in Peru: Lima, Callao, and Arequipa. Our data on viral loads showed the same trends as health indicators such as incidence and mortality. Furthermore, we were able to identify hot spots of contagion within the surveyed urban areas to guide the efforts of health authorities. Viral decay in the sewage network of the cities studied was found to be negligible (<2%). Overall, our results support wastewater monitoring for SARS-CoV-2 as a valuable and cost-effective tool for monitoring the COVID-19 pandemic in the Peruvian context., Competing Interests: The authors declare no competing financial interest., (© 2022 The Authors. Published by American Chemical Society.)
- Published
- 2022
- Full Text
- View/download PDF
36. Laparoscopic adrenalectomy vs. radiofrequency ablation for the treatment of primary aldosteronism. A single center retrospective cohort analysis adjusted with propensity score.
- Author
-
Cano-Valderrama O, González-Nieto J, Abad-Cardiel M, Ochagavía S, Rünkle I, Méndez JV, García-Donaire JA, Cuesta-Hernández M, Armijo JE, Miguel-Novoa P, Torres AJ, and Martell-Claros N
- Subjects
- Adrenalectomy methods, Cohort Studies, Humans, Propensity Score, Retrospective Studies, Treatment Outcome, Hyperaldosteronism surgery, Laparoscopy methods, Radiofrequency Ablation
- Abstract
Background: Laparoscopic adrenalectomy (LA) is the gold standard treatment for unilateral primary aldosteronism. However, satisfactory results have also been published with radiofrequency ablation (RFA). The aim of this study was to compare LA and RFA for the treatment of primary aldosteronism., Methods: A retrospective cohort study of the patients who underwent LA or RFA in a single center was performed. Morbidity and long-term effectiveness (cure rate and blood pressure control) were analyzed. A multivariate analysis with a propensity score was also performed., Results: Thirty-four patients were included in the study, 24 in the LA group and 10 in the RFA group. Hypertension had been diagnosed a median of 12 years before the intervention. Hypertension was properly controlled before the intervention in 55.9% of the patients. Hypertensive crisis was more common during RFA (4.2% vs. 70.0%, p < 0.001), although no patient suffered any complication because of these crises. LA was longer (174.6 vs. 105.5 min, p = 0.001) and had a longer length of stay (median 2 vs 1 days, p < 0.001). No severe complications were observed in any of the patients. After a median follow-up of 46.2 months, more patients had hypertension cured and blood pressure controlled in the LA group (29.2% vs. 0%, p = 0.078 and 95.5% vs. 50.0%, p = 0.006, respectively). Also, patients in the LA group were taking less antihypertensive drugs (1.8 vs. 3.0, p = 0.054) or mineralocorticoid receptor antagonists (41.7% vs. 90.0%, p = 0.020). Multivariate analysis adjusted by propensity score showed that LA had an OR = 11.3 (p = 0.138) for hypertension cure and an OR = 55.1 (p = 0.040) for blood pressure control., Conclusions: Although RFA was a less invasive procedure than LA, hypertension was cured and blood pressure was properly controlled in more patients from the LA group. Patients who underwent LA were taking less antihypertensive drugs than patients who had undergone RFA., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2022
- Full Text
- View/download PDF
37. Is prophylactic mesh closure effective to decrease the incidence of incisional hernia after laparotomy in colorectal surgery?
- Author
-
Cano-Valderrama O, García-Alonso M, Sanz-Ortega G, Rojo M, Catalán V, Domínguez-Serrano I, Dziakova J, Sanz-López R, and Torres AJ
- Subjects
- Humans, Incidence, Laparotomy adverse effects, Retrospective Studies, Surgical Mesh, Abdominal Wound Closure Techniques, Colorectal Surgery, Incisional Hernia epidemiology, Incisional Hernia etiology, Incisional Hernia prevention & control
- Abstract
Background: few studies have studied prophylactic mesh closure after laparotomy for colorectal surgery., Methods: a retrospective cohort study was performed to compare patients with and without prophylactic mesh closure after open colorectal surgery., Results: 309 patients were included from January 2014 to December 2016. Prophylactic mesh closure was performed in 98 patients (31.7%). After a mean follow-up of 21.7 months, incisional hernia was developed in 9 and 54 patients in the group with and without mesh respectively (9.2% vs. 25.7%, OR = 0.3, p = 0.001). In the multivariate Cox model prophylactic mesh closure was associated with a protective effect on incisional hernia development with a Hazard Ratio of 0.46 ( p = 0.033). Surgical site infection was more frequent in the mesh group (19.4% vs. 9.5%, OR = 2.3, p = 0.015)., Conclusions: prophylactic mesh closure is effective to decrease the incidence of incisional hernia after colorectal surgery.
- Published
- 2022
- Full Text
- View/download PDF
38. Reintervention and Survival After Transcatheter Pulmonary Valve Replacement.
- Author
-
McElhinney DB, Zhang Y, Levi DS, Georgiev S, Biernacka EK, Goldstein BH, Shahanavaz S, Qureshi AM, Cabalka AK, Bauser-Heaton H, Torres AJ, Morray BH, Armstrong AK, Millan-Iturbe O, Peng LF, Aboulhosn JA, Rużyłło W, Berger F, Sondergaard L, Schranz D, Cheatham JP, Jones TK, Ewert P, and Schubert S
- Subjects
- Adolescent, Adult, Age Factors, Child, Child, Preschool, Defibrillators, Implantable, Endocarditis epidemiology, Female, Heart Valve Prosthesis, Humans, Infant, Infant, Newborn, Male, Middle Aged, Pacemaker, Artificial, Registries, Young Adult, Heart Valve Prosthesis Implantation mortality, Pulmonary Valve surgery, Reoperation statistics & numerical data
- Abstract
Background: Transcatheter pulmonary valve (TPV) replacement (TPVR) has become the standard therapy for postoperative pulmonary outflow tract dysfunction in patients with a prosthetic conduit/valve, but there is limited information about risk factors for death or reintervention after this procedure., Objectives: This study sought to evaluate mid- and long-term outcomes after TPVR in a large multicenter cohort., Methods: International registry focused on time-related outcomes after TPVR., Results: Investigators submitted data for 2,476 patients who underwent TPVR and were followed up for 8,475 patient-years. A total of 95 patients died after TPVR, most commonly from heart failure (n = 24). The cumulative incidence of death was 8.9% (95% CI: 6.9%-11.5%) 8 years after TPVR. On multivariable analysis, age at TPVR (HR: 1.04 per year; 95% CI: 1.03-1.06 per year; P < 0.001), a prosthetic valve in other positions (HR: 2.1; 95% CI: 1.2-3.7; P = 0.014), and an existing transvenous pacemaker/implantable cardioverter-defibrillator (HR: 2.1; 95% CI: 1.3-3.4; P = 0.004) were associated with death. A total of 258 patients underwent TPV reintervention. At 8 years, the cumulative incidence of any TPV reintervention was 25.1% (95% CI: 21.8%-28.5%) and of surgical TPV reintervention was 14.4% (95% CI: 11.9%-17.2%). Risk factors for surgical reintervention included age (0.95 per year [95% CI: 0.93-0.97 per year]; P < 0.001), prior endocarditis (2.5 [95% CI: 1.4-4.3]; P = 0.001), TPVR into a stented bioprosthetic valve (1.7 [95% CI: 1.2-2.5]; P = 0.007), and postimplant gradient (1.4 per 10 mm Hg [95% CI: 1.2-1.7 per 10 mm Hg]: P < 0.001)., Conclusions: These findings support the conclusion that survival and freedom from reintervention or surgery after TPVR are generally comparable to outcomes of surgical conduit/valve replacement across a wide age range., Competing Interests: Funding Support and Author Disclosures Dr McElhinney has served as a consultant for Medtronic. Dr Levi has served as a consultant for Edwards and Medtronic. Dr Goldstein has served as a consultant for Medtronic. Dr Shahanavaz has served as a consultant for Edwards and Medtronic. Dr Qureshi has served as a consultant for Edwards, Medtronic, W.L. Gore and Associates, and Abiomed Inc. Dr Cabalka has served as a consultant for Medtronic. Dr Torres has served as a proctor for Edwards. Dr Morray has served as a consultant for Medtronic. Dr Armstrong has served as a consultant for Edwards and Medtronic; and has received research grants from Edwards. Dr Aboulhosn has served as a consultant for Edwards and Medtronic; and has received research grants from Edwards. Dr Berger has served as a consultant for Medtronic. Dr Sondergaard has served as a consultant for and received research grants from Edwards and Medtronic. Dr Schranz has served as a consultant for Medtronic. Dr Jones has served as a consultant for and received research grants from Edwards and Medtronic. Dr Cheatham has served as a consultant for Medtronic and NuMED. Dr Schubert has served as a proctor for Abbott, Edwards, Gore, Lifetech, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
39. How should we define cure after parathyroidectomy for normocalcemic primary hyperparathyroidism? A retrospective cohort study.
- Author
-
Cano-Valderrama O, Ochagavía S, Sanabria C, Familiar C, Díaz J, Picazo S, Sáez-Carlin P, and Torres AJ
- Subjects
- Calcium, Humans, Parathyroid Hormone, Retrospective Studies, Hyperparathyroidism, Primary surgery, Parathyroidectomy
- Abstract
Cure after surgery for normocalcemic primary hyperparathyroidism (NHPT) is defined as parathyroid hormone (PTH) normalization. However, an increase of PTH is frequently observed in cured patients with hypercalcemic primary hyperparathyroidism (HHPT). Therefore, this criterion must be redefined. A single-center retrospective study was performed including all patients who underwent surgery for Primary Hyperparathyroidism from 2013 to 2019. Cure rates of different types of hyperparathyroidism were analyzed. PTH reduction was studied as a possible criterion to define cure in patients with NHPT. One-hundred and eighty-six patients were included: 173 with HHPT and 13 with NHPT. After a mean follow-up of 33.4 months, 174 (93.6%) patients were considered cured. Cure was more frequent in the group of patients with HHPT (97.1% vs. 46.2%, p < 0.001). In the multivariate analysis, surgical failure was associated with NHPT and multiglandular disease. Forty-nine (30.1%) cured patients with HHPT had an increased PTH during the follow-up. When decline of PTH levels was studied in patients with HHPT to define cure, the area under curve was 0.92. A cut-off value of 40% in PTH reduction achieved a sensitivity and specificity of 83.4% and 80.0%. If cure was defined as a 40% reduction of PTH, cure rate in the group of patients with NHPT would increase to 69.2%. Patients with NHPT had a lower cure rate than patients with HHPT. A significant number of cured patients with HHPT had an increased PTH during follow-up. A 40% reduction in PTH levels is proposed as an alternative definition for cure in patients with NHPT., (© 2021. Italian Society of Surgery (SIC).)
- Published
- 2021
- Full Text
- View/download PDF
40. Weight Regain Outcomes After Bariatric Surgery in the Long-term Follow-up: Role of Preoperative Factors.
- Author
-
Torrego-Ellacuría M, Barabash A, Larrad-Sainz A, Hernández-Nuñez GM, Matía-Martín P, Pérez-Ferre N, Marcuello C, Sánchez-Pernaute A, Torres AJ, Calle-Pascual AL, and Rubio MA
- Subjects
- Adult, Body Mass Index, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies, Treatment Outcome, Weight Gain, Bariatric Surgery, Diabetes Mellitus, Type 2 surgery, Obesity, Morbid surgery
- Abstract
Purpose: Weight regain (WR) compromises the effectiveness of bariatric surgery. The objective of this study was to determine differences in long-term WR prevalence using different definitions and analyze possible preoperative predictors involved., Methods: Single-center retrospective cohort study including 445 adults who underwent 3 modalities of bariatric surgery between 2009 and 2014., Exposure: age, gender, ethnicity, body mass index (BMI), type 2 diabetes (T2D), hypertension (HTN), and type of surgery., Main Outcomes: WR at year 6 assessed by 4 definitions and 6 multivariate models based on common thresholds., Results: Our cohort (71.1% female) had a mean age of 44.78 ± 11.94 years, and mean presurgery BMI of 44.94 ± 6.88 kg/m
2 , with a median follow-up of 6 years (IQR=5-8). The prevalences of T2D and HTN were 36.0% and 46.7% respectively. WR rates over thresholds ranged from 25.4 to 68.1%, with significant differences between groups in the WR measured as the percentage of maximum weight loss (MWL) and the increase in excess weight loss (EWL). Presurgery BMI was a significant predictor in 3 models; restrictive techniques were associated with WR in all the models except for those considering WR over 10 kg and WR over 15% from nadir as dependent variables., Conclusions: In this long-term study, WR defined as percentage of MWL and increase in EWL from nadir had the greatest significance in logistic regression models with preoperative BMI and type of surgery as independent variables. These findings could serve to establish a standardized outcome reporting WR in other longitudinal studies., Key Points: • Lack of standardized outcome to measure weight regain after bariatric surgery. • Lowest rates of weight regain in malabsorptive techniques in all definitions applied. • Weight regain measured as percentage of maximum weight lost., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)- Published
- 2021
- Full Text
- View/download PDF
41. Effect of long-term individual cognitive stimulation intervention for people with mild neurocognitive disorder.
- Author
-
Justo-Henriques SI, Otero P, Torres AJ, and Vázquez FL
- Subjects
- Activities of Daily Living, Aged, Aged, 80 and over, Attention, Cognitive Dysfunction psychology, Depression etiology, Depression therapy, Disease Progression, Executive Function, Female, Humans, Language, Male, Memory, Mental Status and Dementia Tests, Middle Aged, Personal Autonomy, Cognitive Dysfunction therapy, Games, Recreational psychology
- Abstract
Introduction: Cognitive stimulation may be beneficial in slowing the progression of mild neurocognitive disorder (NCD), but the results of existing research are inconsistent. Furthermore, there are no long-term interventions nor individual (one-on-one) interventions applied by professionals. Objetive. The aim of this study was to assess the efficacy of a long-term individual cognitive stimulation intervention on people with mild NCD., Patients and Methods: A pre-post test design with a non-equivalent control group was conducted. A total of 82 participants with mild NCD were assigned to a cognitive stimulation intervention group or to a control group. The intervention consisted of 88 individual format sessions of approximately 45 minutes, twice per week. Independent evaluators assessed cognition, depressive symptomatology and autonomy level in activities of daily living at pre-intervention, intra-intervention (6 months) and post-intervention (12 months)., Results: At intra- and post-intervention, significant improvement on cognition and depressive symptomatology in the intervention group compared to the control group were found. Younger participants and those with better cognitive function and status in pre-intervention achieved better results. Adherence to the intervention was high., Conclusions: Results suggest the efficacy of long-term individual cognitive intervention in people with mild NCD, which could delay the progression towards a major NCD.
- Published
- 2021
- Full Text
- View/download PDF
42. Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement.
- Author
-
McElhinney DB, Zhang Y, Aboulhosn JA, Morray BH, Biernacka EK, Qureshi AM, Torres AJ, Shahanavaz S, Goldstein BH, Cabalka AK, Bauser-Heaton H, Georgiev S, Berger F, Millan-Iturbe O, Peng LF, Armstrong AK, Levi DS, Fronczak-Jakubczyk A, Sondergaard L, Anderson JH, Schranz D, Jones TK, Cheatham JP, Schubert S, and Ewert P
- Subjects
- Adult, Cardiac Catheterization methods, Female, Humans, Incidence, International Cooperation, Male, Registries statistics & numerical data, Staphylococcus aureus isolation & purification, Ventricular Outflow Obstruction etiology, Ventricular Outflow Obstruction surgery, Viridans Streptococci isolation & purification, Endocarditis etiology, Endocarditis microbiology, Endocarditis mortality, Endocarditis surgery, Heart Valve Prosthesis Implantation adverse effects, Heart Valve Prosthesis Implantation methods, Heart Valve Prosthesis Implantation statistics & numerical data, Pulmonary Valve surgery, Reoperation methods, Reoperation statistics & numerical data
- Abstract
Background: Endocarditis has emerged as one of the most impactful adverse events after transcatheter pulmonary valve replacement (TPVR), but there is limited information about risk factors for and outcomes of this complication., Objectives: The purpose of this study was to evaluate risk factors for and outcomes of endocarditis in a large multicenter cohort., Methods: The authors established an international registry focused on characterizing endocarditis after TPVR, including the incidence, risk factors, characteristics, and outcomes., Results: Investigators submitted data for 2,476 patients who underwent TPVR between July 2005 and March 2020 and were followed for 8,475 patient-years. In total, 182 patients were diagnosed with endocarditis a median of 2.7 years after TPVR, for a cumulative incidence of 9.5% (95% CI: 7.9%-11.1%) at 5 years and 16.9% (95% CI: 14.2%-19.8%) at 8 years (accounting for competing risks: death, heart transplant, and explant) and an annualized incidence of 2.2 per 100 patient-years. Staphylococcus aureus and Viridans group Streptococcus species together accounted for 56% of cases. Multivariable analysis confirmed that younger age, a previous history of endocarditis, and a higher residual gradient were risk factors for endocarditis, but transcatheter pulmonary valve type was not. Overall, right ventricular outflow tract (RVOT) reintervention was less often to treat endocarditis than for other reasons, but valve explant was more often caused by endocarditis. Endocarditis was severe in 44% of patients, and 12 patients (6.6%) died, nearly all of whom were infected with Staphylococcus aureus., Conclusions: The incidence of endocarditis in this multicenter registry was constant over time and consistent with prior smaller studies. The findings of this study, along with ongoing efforts to understand and mitigate risk, will be critical to improve the lifetime management of patients with heart disease involving the RVOT. Although endocarditis can be a serious adverse outcome, TPVR remains an important tool in the management of RVOT dysfunction., Competing Interests: Funding Support and Author Disclosures Drs McElhinney, Morray, Goldstein, Cabalka, Berger, and Schranz have served as consultants for Medtronic. Drs Aboulhosn and Levi have served as consultants for Edwards and Medtronic; and has received research grants from Edwards. Dr Qureshi has served as a consultant for Edwards, Medtronic, W.L. Gore and Associates, and Abiomed Inc. Dr Torres has served as a proctor for Edwards. Dr Shahanavaz has served as a consultant for Edwards and Medtronic. Dr Armstrong has served as a consultant for Edwards and Medtronic; and has received research grants from Edwards. Dr Sondergaard has served as a consultant for Edwards and Medtronic; and has received research grants from Edwards and Medtronic. Dr Jones has served as a consultant for Edwards and Medtronic; and has received research grants from Edwards and Medtronic. Dr Cheatham has served as a consultant for Medtronic and NuMED. Dr Schubert has served as a proctor for Abbott, Edwards, Gore, Lifetech, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
43. Trocar-site incisional hernia after laparoscopic colorectal surgery: a significant problem? Incidence and risk factors from a single-center cohort.
- Author
-
Cano-Valderrama O, Sanz-López R, Sanz-Ortega G, Anula R, Romera JL, Rojo M, Catalán V, Mugüerza J, and Torres AJ
- Subjects
- Aged, Humans, Incidence, Retrospective Studies, Risk Factors, Surgical Instruments adverse effects, Colorectal Surgery, Incisional Hernia epidemiology, Incisional Hernia etiology, Incisional Hernia surgery, Laparoscopy adverse effects
- Abstract
Background: Trocar-site incisional hernia (TSIH) after laparoscopic surgery has been scarcely studied. TSIH incidence and risk factors have never been properly studied for laparoscopic colorectal surgery., Methods: A retrospective analytic study in a tertiary hospital was performed including patients who underwent elective laparoscopic colorectal surgery between 2014 and 2016. Clinical and radiological TSIH were analyzed., Results: 272 patients with a mean age of 70.7 years were included. 205 (75.4%) underwent surgery for a malignant disease. The most common procedure was right colectomy (108 patients, 39.7%). After a mean follow-up of 30.8 months 64 (23.5%) patients developed a TSIH. However, only 7 out of 64 (10.9%) patients with a TSIH underwent incisional hernia repair. That means that 2.6% of all the patients underwent TSIH repair. 44 (68.8%) patients had TSIH in the umbilical Hasson trocar. In the multivariate analysis, the existence of an umbilical Hasson trocar orifice was the only statistically significant risk factor for TSIH development., Conclusions: Incidence of TSIH was high, although few patients underwent incisional hernia repair. Most TSIH were observed in the umbilical Hasson trocar, which was the only risk factor for TSIH development in the multivariate analysis. Efforts should be addressed to avoid TSIH in the umbilical Hasson trocar.
- Published
- 2021
- Full Text
- View/download PDF
44. The IFSO Worldwide One Anastomosis Gastric Bypass Survey: Techniques and Outcomes?
- Author
-
Haddad A, Bashir A, Fobi M, Higa K, Herrera MF, Torres AJ, Himpens J, Shikora S, Ramos AC, Kow L, and Nimeri AA
- Subjects
- Gastrectomy, Humans, Weight Loss, Bile Reflux, Gastric Bypass, Obesity, Morbid surgery
- Abstract
Introduction: One anastomosis gastric bypass (OAGB) has become one of the most commonly performed gastric bypass procedures in some countries., Objectives: To assess how surgeons viewed the OAGB, perceptions, indications, techniques, and outcomes, as well as the incidence of short- and long-term complications and how they were managed worldwide., Methods: A questionnaire was sent to all IFSO members in all 5 chapters to study the pattern of practice and outcomes of OAGB., Results: Seven hundred and forty-two surgeons responded. The most commonly performed procedures were sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and OAGB. Preoperatively, 70% of the surgeons performed endoscopy routinely. In regards to weight loss, 83% (570 surgeons) responded that OAGB produces better weight loss than SG, and 49% (342 surgeons) responded that OAGB produces better weight loss than RYGB. The most common length of the biliopancreatic limb (BPL) utilized was 200 cm. Sixty-seven percent of surgeons did not measure the total length of the small bowel. In patients with reflux disease and history of smoking, 53% and 22% of surgeons respectively still offered OAGB as a treatment option. Postoperatively, leak was documented in 963 patients, and it was the leading cause for mortality. Leak management was conservative in 35%. Conversion to RYGB was performed in 31%. In 16% the anastomosis was reinforced, 6% of the patients were reversed, and other procedures were performed in 12%. Revision of OAGB for malnutrition/steatorrhea or severe bile reflux was reported at least once by 37% and 45% of surgeons, respectively (200 cm was the most commonly encountered biliopancreatic limb BPL in those revised for malnutrition). Most common strategy for revision was conversion to RYGB (43%), reversal to normal anatomy (32%), shortening of the BPL (20%), and conversion to SG (5%). Nevertheless, 5 out of 98 mortalities (5%) were due to liver failure/malnutrition., Conclusion: There are infrequent but potentially severe specific complications including malnutrition, liver failure, and bile reflux that may require surgical correction after OAGB.
- Published
- 2021
- Full Text
- View/download PDF
45. Returning to Surgery-Experience, Discussions and Consensus.
- Author
-
Kroh M, Prager G, Rubino F, Marinari GM, Torres AJ, Somers S, Akın F, and Haskins O
- Subjects
- Consensus, Humans, Obesity, Morbid surgery
- Published
- 2021
- Full Text
- View/download PDF
46. The First Modified Delphi Consensus Statement for Resuming Bariatric and Metabolic Surgery in the COVID-19 Times.
- Author
-
Pouwels S, Omar I, Aggarwal S, Aminian A, Angrisani L, Balibrea JM, Bhandari M, Biter LU, Blackstone RP, Carbajo MA, Copaescu CA, Dargent J, Elfawal MH, Fobi MA, Greve JW, Hazebroek EJ, Herrera MF, Himpens JM, Hussain FA, Kassir R, Kerrigan D, Khaitan M, Kow L, Kristinsson J, Kurian M, Lutfi RE, Moore RL, Noel P, Ozmen MM, Ponce J, Prager G, Purkayastha S, Rafols JP, Ramos AC, Ribeiro RJS, Sakran N, Salminen P, Shabbir A, Shikora SA, Singhal R, Small PK, Taylor CJ, Torres AJ, Vaz C, Yashkov Y, and Mahawar K
- Subjects
- Consensus, Delphi Technique, Humans, Obesity, Morbid surgery, Pandemics, SARS-CoV-2, Bariatric Surgery, COVID-19
- Abstract
The purpose of this study was to achieve consensus amongst a global panel of expert bariatric surgeons on various aspects of resuming Bariatric and Metabolic Surgery (BMS) during the Coronavirus Disease-2019 (COVID-19) pandemic. A modified Delphi consensus-building protocol was used to build consensus amongst 44 globally recognised bariatric surgeons. The experts were asked to either agree or disagree with 111 statements they collectively proposed over two separate rounds. An agreement amongst ≥ 70.0% of experts was construed as consensus as per the predetermined methodology. We present here 38 of our key recommendations. This first global consensus statement on the resumption of BMS can provide a framework for multidisciplinary BMS teams planning to resume local services as well as guide future research in this area.
- Published
- 2021
- Full Text
- View/download PDF
47. Race differences in predictors of weight gain among a community sample of smokers enrolled in a randomized controlled trial of a multiple behavior change intervention.
- Author
-
Tan MM, Bush T, Lovejoy JC, Javitz H, Torres AJ, Wassum K, and Spring B
- Abstract
African Americans have disproportionate rates of post-cessation weight gain compared to non-Hispanic whites, but few studies have examined this weight gain in a multiracial sample of smokers receiving evidence-based treatment in a community setting. We examined race differences in short-term weight gain during an intervention to foster smoking cessation plus weight management. Data were drawn from the Best Quit Study, a randomized controlled trial conducted via telephone quitlines across the U.S. from 2013 to 2017. The trial tested the effects on cessation and weight gain prevention of adding a weight control intervention either simultaneously with or sequentially after smoking cessation treatment. African Americans (n = 665) and whites (n = 1723) self-reported smoking status and weight during ten intervention calls. Random effects longitudinal modeling was used to examine predictors of weight change over the intervention period (average 16 weeks). There was a significant race × treatment effect; in the simultaneous group, weight increased for African Americans at a faster rate compared to whites (b = 0.302, SE = 0.129, p < 0.05), independent of smoking status, age, baseline obesity, and education. After stratifying the sample, the effect of treatment group differed by race. Education level attenuated the rate of weight gain for African Americans in the simultaneous group, but not for whites. African Americans receiving smoking and weight content simultaneously gained weight faster than whites in the same group; however, the weight gain was slower for African Americans with higher educational attainment. Future studies are needed to understand social factors associated with treatment receptivity that may influence weight among African American smokers., Competing Interests: The authors at Alere Wellbeing (TB, AJT, and KW) declare that they are employed by Alere Wellbeing (a subsidiary of Optum) which provides tobacco cessation and weight management services to states and commercial clients. They have no other competing interests. MT, JCL, HJ, and BS have no conflicts to disclose. No financial disclosures were reported by the authors of this paper., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
48. Transcatheter Pulmonary Valve Replacement With the Sapien Prosthesis.
- Author
-
Shahanavaz S, Zahn EM, Levi DS, Aboulhousn JA, Hascoet S, Qureshi AM, Porras D, Morgan GJ, Bauser Heaton H, Martin MH, Keeshan B, Asnes JD, Kenny D, Ringewald JM, Zablah JE, Ivy M, Morray BH, Torres AJ, Berman DP, Gillespie MJ, Chaszczewski K, Zampi JD, Walsh KP, Julien P, Goldstein BH, Sathanandam SK, Karsenty C, Balzer DT, and McElhinney DB
- Subjects
- Adolescent, Adult, Bioprosthesis, Child, Endovascular Procedures instrumentation, Endovascular Procedures methods, Female, Heart Valve Prosthesis Implantation instrumentation, Heart Valve Prosthesis Implantation methods, Humans, Male, Middle Aged, Retrospective Studies, Young Adult, Endovascular Procedures statistics & numerical data, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation statistics & numerical data, Pulmonary Valve, Registries
- Abstract
Background: There are limited published data focused on outcomes of transcatheter pulmonary valve replacement (TPVR) with either a Sapien XT or Sapien 3 (S3) valve., Objectives: This study sought to report short-term outcomes in a large cohort of patients who underwent TPVR with either a Sapien XT or S3 valve., Methods: Data were entered retrospectively into a multicenter registry for patients who underwent attempted TPVR with a Sapien XT or S3 valve. Patient-related, procedural, and short-term outcomes data were characterized overall and according to type of right ventricular outflow tract (RVOT) anatomy., Results: Twenty-three centers enrolled a total of 774 patients: 397 (51%) with a native/patched RVOT; 183 (24%) with a conduit; and 194 (25%) with a bioprosthetic valve. The S3 was used in 78% of patients, and the XT was used in 22%, with most patients receiving a 29-mm (39%) or 26-mm (34%) valve. The implant was technically successful in 754 (97.4%) patients. Serious adverse events were reported in 67 patients (10%), with no difference between RVOT anatomy groups. Fourteen patients underwent urgent surgery. Nine patients had a second valve implanted. Among patients with available data, tricuspid valve injury was documented in 11 (1.7%), and 9 others (1.3%) had new moderate or severe regurgitation 2 grades higher than pre-implantation, for 20 (3.0%) total patients with tricuspid valve complications. Valve function at discharge was excellent in most patients, but 58 (8.5%) had moderate or greater pulmonary regurgitation or maximum Doppler gradients >40 mm Hg. During limited follow-up (n = 349; median: 12 months), 9 patients were diagnosed with endocarditis, and 17 additional patients underwent surgical valve replacement or valve-in-valve TPVR., Conclusions: Acute outcomes after TPVR with balloon-expandable valves were generally excellent in all types of RVOT. Additional data and longer follow-up will be necessary to gain insight into these issues., Competing Interests: Author Disclosures This study received funding from Edwards Lifesciences, Inc., to support data management and analysis, but there was no direct participation by employees of Edwards Lifesciences, Inc. Drs. Aboulhosn, Asnes, and Torres have served as proctors for Edwards Lifesciences. Dr. Balzer has served as a proctor for Edwards Lifesciences and Medtronic. Drs. Berman and Zahn have served as a proctor and consultant for Edwards Lifesciences, Abbott, and Medtronic. Dr. Gillespie has served as a consultant for Medtronic. Dr. Goldstein has served as a consultant for Medtronic; has served as a consultant and proctor for W.L. Gore & Associates; and has served on the PECA Labs Advisory Board. Dr. Levi has served as a consultant and proctor for Edwards Lifesciences. Dr. McElhinney has served as a consultant and proctor for Medtronic. Dr. Morgan has served as a consultant and proctor for Edwards Lifesciences; and has served as a consultant for Medtronic. Dr. Murray has served as a consultant for Medtronic and Abbott. Dr. Shahanavaz has served as a proctor for Edwards Lifesciences and Medtronic. Dr. Sathanandam has served as a proctor and consultant for Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
49. Marijuana Use and Adherence to Smoking Cessation Treatment Among Callers to Tobacco Quitlines.
- Author
-
Carpenter KM, Torres AJ, Salmon EE, Carlini BH, Vickerman KA, Schauer GL, and Bush T
- Subjects
- Adult, Alaska, District of Columbia, Female, Humans, Male, Oregon, Tobacco Use, Young Adult, Counseling, Marijuana Use, Smoking Cessation
- Abstract
Introduction: Tobacco kills over half a million adults annually in the United States. Most smokers want to quit, and over 400,000 call state-funded quitlines for help each year. Marijuana use among tobacco users is common and may impede quitting, but co-use rates among quitline callers are unknown. The purpose of our observational study was to describe marijuana use among quitline callers in states with legalized marijuana., Methods: Participants were 1,059 smokers aged 21 or older from Oregon, Alaska, and Washington, DC, who called quitlines from September through December 2016. Data on quitline callers' demographics, tobacco and marijuana use, and quitline use were collected. We used χ
2 and regression analyses to compare marijuana users with nonusers on demographic characteristics and quitline use., Result: Among quitline callers in our study, 24% reported using marijuana in the past 30 days: 28.9% in Alaska, 16.7% in Washington, DC, and 25.0% in Oregon (P = .009). Current users, compared with non-users (n = 772), were less likely to be women (48.4% vs 62.0%, respectively, P < .001). Current marijuana users were less likely to be given nicotine replacement therapy (68.4%) than current nonusers (74.1%) (P < .001), but more likely to complete 3 or more counseling calls (P = .005). Of those who used marijuana in the past 30 days, 62.3% used marijuana on 1 to 19 days, 9.0% used on 20 to 29 days, and 28.7% on all 30 days. Among current marijuana users, the percentage who wanted to quit or reduce marijuana use (42.6%) was higher in Alaska (54.6%) and the District of Columbia (56.8%) than in Oregon (37.9%), P = .03., Conclusion: One in 4 quitline callers reported past 30-day marijuana use. Given that nearly half (43%) wanted to reduce marijuana use, addressing co-use may be an important addition to quitline treatment. Future studies should assess co-use effects on tobacco cessation outcomes and explore combined treatment or bidirectional referrals between quitlines and marijuana treatment providers.- Published
- 2020
- Full Text
- View/download PDF
50. Extraction-site incisional hernia after laparoscopic colorectal surgery: should we carry out a study about prophylactic mesh closure?
- Author
-
Cano-Valderrama O, Sanz-López R, Domínguez-Serrano I, Dziakova J, Catalán V, Rojo M, García-Alonso M, Mugüerza JM, and Torres AJ
- Subjects
- Aged, Blood Pressure, Body Mass Index, Confidence Intervals, Female, Humans, Incisional Hernia epidemiology, Incisional Hernia physiopathology, Male, Multivariate Analysis, Odds Ratio, Retrospective Studies, Risk Factors, Colorectal Surgery adverse effects, Incisional Hernia etiology, Laparoscopy adverse effects, Surgical Mesh adverse effects
- Abstract
Background: Prophylactic mesh closure has only scarcely been studied to avoid extraction-site incisional hernia after laparoscopic colorectal surgery. The aim was to analyze extraction-site incisional hernia incidence after laparoscopic colorectal surgery to assess if prophylactic mesh closure should be studied., Methods: A retrospective analytic cohort study was conducted in patients who had undergone laparoscopic colorectal surgery with an extraction-site incision. Extraction-site incisional hernia was diagnosed during clinical examination or imaging. Risk factors for extraction-site incisional hernia were analyzed., Results: Two hundred and twenty-five patients were included. More than 80% of the patients had a malignant disease. Ninety-two patients (40.9%) underwent right colectomy. Midline extraction-site incision was used in 86 (38.2%) patients. After a mean follow-up of 2.4 years, 39 (17.3%) patients developed an extraction-site incisional hernia. Midline extraction-site incision was associated with incisional hernia when compared to transverse and Pfannenstiel incision (39.5% vs. 3.6%, OR 17.5, p < 0.001). Surgery to repair an extraction-site incisional hernia was also more frequent in the group of patients with a midline incision (10.5% vs. 1.4%, OR 8.0, p = 0.002). In the multivariate analysis, incisional hernia was associated with body mass index, high blood pressure, and midline incision., Conclusions: Extraction-site incisional hernia was mainly related to midline incisions; therefore, midline incision should be avoided whenever possible. Studying prophylactic mesh closure for Pfannesnstiel or transverse incisions is needless, as these incisions have a low incisional hernia risk.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.